Podcasts about Informa

Mais um conteúdo no ar! Fred Figueiroa e Cássio Zirpoli fazem um verdadeiro manual de onde e quais competições vão transmitir cada uma das 8 competições organizadas pela CBF. TV Aberta, TV fechada, streaming, quais são as opções para o torcedor acompanhar o seu time. Na edição, Gabriel Costa. Ouça agora ou quando quiser!

⁠⁠⁠Enio Augusto⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ e ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Marcos Buosi⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ falam sobre tudo que envolve o mundo dos tênis e também de outros acessórios relacionados à corrida.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠SEJA MEMBRO DO CANAL!!!⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Aqui tem análises, reviews, dicas, palpites, perguntas, respostas, números, valores e opinião. Informação com bom humor, dúvidas com resposta e conteúdo de sobra. Envie sua pergunta. Escute, aprenda, ensine e divirta-se com a gente.-O protótipo do Alphafly 4 da Nike que Jacob Kiplimo usou para fazer o recorde mundial na Meia Maratona de Lisboa.Usar super tênis na maratona vale a pena?-Cupom de Desconto:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠CORRA BARATO⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ - PFC⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠KEEP RUNNING BRASIL⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ - PFC

Confira os destaques do Jornal da Manhã desta quarta-feira (11): O Comando Central dos Estados Unidos divulgou um vídeo afirmando mostrar ataques contra embarcações iranianas próximas ao Estreito de Ormuz. Segundo comunicado oficial, as forças americanas teriam destruído 16 navios lança-minas do Irã durante a operação realizada nesta terça-feira (10). A ação ocorre em meio à escalada do conflito na região. O presidente Donald Trump também alertou que qualquer mina naval colocada pelo Irã no estreito deve ser removida imediatamente. A oposição acionou o Supremo Tribunal Federal para tentar obrigar o presidente do Congresso, senador Davi Alcolumbre, a instalar a CPMI que pretende investigar o caso do Banco Master. O pedido foi apresentado em fevereiro e já conta com 42 assinaturas de senadores e 236 de deputados, número superior ao mínimo exigido para a criação da comissão. No recurso ao STF, os parlamentares argumentam que a Constituição garante o direito das minorias de instaurar CPIs, citando como precedente a decisão da Corte que determinou a instalação da CPI da Pandemia em 2021. A intenção é investigar possíveis irregularidades envolvendo o banco e eventuais repercussões políticas. O presidente Lula (PT) desistiu de comparecer à cerimônia de posse do novo presidente do Chile, José Antonio Kast, marcada para esta quarta-feira (11). O ministro das Relações Exteriores, Mauro Vieira, representará o Brasil no evento. Informações de bastidores indicam que o mandatário do país sentiu desconforto com a presença do senador e pré-candidato Flávio Bolsonaro (PL). A Comissão de Segurança Pública da Câmara dos Deputados aprovou três requerimentos relacionados à morte de Luiz Phillipi Machado de Moraes Mourão, conhecido como “Sicário”, investigado no escândalo envolvendo o Banco Master. Mourão estava preso na Superintendência da Polícia Federal em Belo Horizonte quando tentou tirar a própria vida. Ele foi socorrido e levado a um hospital, mas morreu dias depois. Entre as medidas aprovadas pelos parlamentares está o convite ao diretor-geral da Polícia Federal, Andrei Rodrigues, para prestar esclarecimentos sobre o caso e as circunstâncias da morte. O Ministério das Relações Exteriores de Israel acusou o Irã de utilizar bombas de fragmentação em ataques contra civis israelenses. A declaração foi publicada no perfil oficial da pasta na rede social X nesta terça-feira (10). Esse tipo de armamento libera múltiplos explosivos menores que se espalham por grandes áreas e podem permanecer ativos por anos ou até décadas, transformando regiões atingidas em áreas perigosas semelhantes a campos minados. O Ministério da Justiça enviou um ofício ao TikTok dando prazo de cinco dias para que a plataforma explique a circulação da trend “se ela disser não”. Nos vídeos, homens simulam reações violentas contra mulheres após receberem uma negativa em pedidos de relacionamento ou casamento. A pasta afirmou que a responsabilidade da rede social não se limita à remoção de conteúdos específicos solicitada pela Polícia Federal, mas também à retirada imediata de conteúdos que incentivem violência, independentemente de notificação oficial. O major Rafael Rosenshein, porta-voz do Exército de Israel, concedeu entrevista ao Jornal da Manhã e explicou as ações realizadas pelas forças israelenses durante a guerra contra o Irã. Ele detalhou os objetivos militares das operações, o avanço dos ataques e a estratégia adotada por Israel diante da escalada do conflito no Oriente Médio. Essas e outras notícias você acompanha no Jornal da Manhã. Learn more about your ad choices. Visit megaphone.fm/adchoices

Nesta edição, exploramos os detalhes fundamentais sobre o primeiro guia prático da OMS para acelerar a eliminação das hepatites B e C, com foco na simplificação do diagnóstico e na remoção de barreiras de acesso aos antivirais. Analisamos a aprovação pela Anvisa do cenobamato como terapia adjuvante para adultos com epilepsia focal farmacorresistente, oferecendo uma nova perspectiva para pacientes refratários. Por fim, destacamos o marco histórico de Singapura, que atingiu o nível máximo da OMS na regulação de dispositivos médicos, elevando o padrão global para tecnologias de saúde e software clínico.Afya News. Informação médica confiável e atualizada no seu tempo.Fontes do episódio aqui:⁠https://portal.afya.com.br/podcasts/afya-news/11-03-2026

Prepare-se para a segunda metade do dia sabendo de tudo que mexeu com o mercado nas primeiras horas do pregão. Informação e análise com Roberto Motta. O Resumo da Manhã é transmitido de segunda a sexta, às 13h. Ative as notificações do programa e acompanhe ao vivo!

Falamos do Santa Cruz, dentro e fora de campo.

Povestea lui Vladislav Duda, un tânăr care a ales să fugă din calea războiului traversând munții Maramureșului, reprezintă o mărturie dureroasă despre curajul disperat și realitățile brutale ale supraviețuirii. Deși mulți dintre cei care încearcă să treacă această graniță sunt induși în eroare de informații false, crezând că au de parcurs doar câțiva kilometri până la siguranță, în realitate se confruntă cu un traseu extrem de dificil, de peste 20 de kilometri, care poate dura ore întregi chiar și pentru alpiniști experimentați. Muntele, în special partea românească, devine un loc al tragediei pentru cei neechipați, unde condițiile meteo și terenul aspru transformă o încercare de salvare într-o luptă inegală cu moartea. Dincolo de pericolele fizice, acești oameni poartă traume psihice profunde, mulți dorind să lase totul în urmă și să își reseteze complet viața, refuzând să se mai întoarcă la locurile devastate de conflict. Discuția cu Dan Benga, salvamontistul care a fost martor la sute de astfel de drame, subliniază efortul supraomenesc al echipei de salvare, care continuă să caute supraviețuitori în condiții limită, încercând să ofere răspunsuri disperate pentru familiile care așteaptă un semn de viață. Este o realitate dură, aflată chiar la granița noastră, care ne forțează să înțelegem că, dincolo de știrile de la televizor, există suferințe pe care nici măcar nu ni le putem imagina. IGDLCC înseamnă Informații Gratis despre Lucruri care Costă! Totul ne costă dar mai ales timpul așa că am făcut această serie pentru a mă informa și educa alături de invitați din domeniile mele de interes. Te invit alături de mine în această călătorie. Mi-am propus să mă facă mai informat și mai adaptat la schimbările care vin. Sper să o facă și pentru tine.

No 3 em 1 desta terça-feira (10), o destaque foi os Estados Unidos que afirmaram que os bombardeios contra o Irã serão mais intensos nesta terça-feira (10). Em resposta à ofensiva de Washington, o chefe do Conselho Supremo de Segurança Nacional do Irã, Ali Larijani, disse para o presidente Donald Trump ter cuidado para não ser eliminado. O mandatário iraniano afirmou que o regime não teme as ameaças vazias vindas da Casa Branca. Reportagem: Eliseu Caetano e Luca Bassani. O presidente Lula (PT) desistiu de comparecer à cerimônia de posse do novo presidente do Chile, José Antonio Kast, marcada para esta quarta-feira (11). O ministro das Relações Exteriores, Mauro Vieira, representará o Brasil no evento. Informações de bastidores indicam que o mandatário do país sentiu desconforto com a presença do senador e pré-candidato Flávio Bolsonaro (PL). Reportagem: André Anelli. A Primeira Turma do Supremo Tribunal Federal iniciou o julgamento dos deputados federais Josimar Cunha Rodrigues (PL) e Gildenemir de Lima Sousa (PL), além do ex-deputado João Bosco da Costa (PL). Segundo a Procuradoria-Geral da República, o grupo cobrou R$ 1,6 milhão em propina para liberar emendas destinadas ao estado do Maranhão. Reportagem: Janaína Camelo. O presidente do Supremo Tribunal Federal, Edson Fachin, manifestou apoio à condução do ministro André Mendonça na relatoria do Caso Banco Master nas investigações envolvendo a rede de Daniel Vorcaro. O líder da Corte realizou uma reunião com ministros nesta segunda-feira (09). Reportagem: Janaína Camelo. A bancada do Partido Novo no Senado protocolou uma representação no Conselho de Ética pedindo o afastamento imediato do presidente da Casa, Davi Alcolumbre (União). A legenda acusa o parlamentar de omissão institucional e abuso de poder por travar a abertura da CPI do Banco Master. Reportagem: Beatriz Souza. O presidente Lula (PT) e o ministro da Fazenda, Fernando Haddad (PT), reuniram-se nesta terça-feira (10) para discutir os impactos econômicos da guerra no Oriente Médio. O mandatário do país e o chefe da pasta econômica avaliam a volatilidade do preço do petróleo e as pressões e impactos possíveis contra o Brasil. Reportagem: Julia Fermino. A Comissão Parlamentar Mista de Inquérito (CPMI) do INSS protocolou um recurso no Supremo Tribunal Federal contra a decisão do ministro Flávio Dino. O magistrado havia determinado a suspensão das quebras de sigilo de investigados. Reportagem: Beatriz Souza. O senador Ciro Nogueira (PP), presidente nacional do Progressistas, assinou o pedido de abertura de uma Comissão Parlamentar de Inquérito para investigar a relação de ministros com o Banco Master. O parlamentar é apontado como um dos citados em relatórios que detalham a rede de influência do banqueiro Daniel Vorcaro. Reportagem: Beatriz Souza. O presidente do Supremo Tribunal Federal, Edson Fachin, defendeu um distanciamento saudável do Judiciário, afirmando que a Justiça não pode ficar presa em conveniências. O recado mira os desdobramentos do Caso Banco Master e a discussão sobre os penduricalhos. O mandatário também falou sobre um novo Código de Ética para a Corte. Reportagem: Janaína Camelo. Uma pesquisa do instituto Datafolha revela que 9% dos eleitores apontam a corrupção como o principal problema do país. A saúde lidera o ranking de preocupações com 21%, seguida pela segurança pública, citada por 19% dos entrevistados, economia com 11% e educação empatada com corrupção. O levantamento reflete as prioridades da população para o cenário nacional em 2026. Tudo isso e muito mais você acompanha no 3 em 1. Learn more about your ad choices. Visit megaphone.fm/adchoices

O panorama da saúde de hoje traz os principais tópicos do 2º Fórum da Mulher Médica, abordando como a maioria feminina na profissão está a redefinir liderança, jornadas de trabalho e a cultura dos serviços de saúde. Analisamos também a discussão recente do NEJM sobre a individualização das metas de pressão arterial, reforçando a importância de equilibrar os benefícios cardiovasculares com os riscos, especialmente em pacientes idosos e frágeis. Por fim, acompanhamos o movimento de consolidação da saúde digital com a aquisição da Talkspace por uma grande rede hospitalar, sinalizando uma integração mais profunda entre o teleatendimento em saúde mental e o cuidado presencial. Afya News. Informação médica confiável e atualizada no seu tempo.Fontes do episódio aqui:⁠https://portal.afya.com.br/podcasts/afya-news/10-03-2026

Prepare-se para a segunda metade do dia sabendo de tudo que mexeu com o mercado nas primeiras horas do pregão. Informação e análise com Roberto Motta. O Resumo da Manhã é transmitido de segunda a sexta, às 13h. Ative as notificações do programa e acompanhe ao vivo!

Esta edição destaca um marco na medicina de transplantes: o primeiro uso de um fígado de porco geneticamente modificado como suporte extracorpóreo para manter um paciente humano vivo. O boletim detalha a Nota Técnica nº 3 de 2026 do Ministério da Saúde, que estabelece novas orientações para o registo e notificação de anomalias congénitas no SUS, integrando-as à vigilância epidemiológica nacional. Apresentamos também um estudo recente que identificou mais de 70 condições clínicas que podem sinalizar o risco futuro de Alzheimer anos antes do diagnóstico. Acompanhe as atualizações que impulsionam a precisão diagnóstica e a inovação cirúrgica no seu podcast diário de atualização, com curadoria médica e produzido por IA.Afya News. Informação médica confiável e atualizada no seu tempo.Fontes do episódio aqui:⁠https://portal.afya.com.br/podcasts/afya-news/09-03-2026

Conversamos com o professor brasileiro Mathias Felipe de Lima Santos, da UNSW, que estuda a intersecção entre jornalismo e tecnologia e tem ao menos 27 estudos publicados sobre o tema em periódicos acadêmicos classificados como de primeira linha. Ele explica os cenários possíveis com a introdução massiva da inteligência artificial na indústria da informação, e dá sugestões de como o cidadão comum pode se precaver de informações falsas no universo guiado por algoritmos de funcionamento obscuro.

Prepare-se para a segunda metade do dia sabendo de tudo que mexeu com o mercado nas primeiras horas do pregão. Informação e análise com Roberto Motta. O Resumo da Manhã é transmitido de segunda a sexta, às 13h. Ative as notificações do programa e acompanhe ao vivo!

Cine l-a răpit pe Nicușor Dan. O cronologie (Republica) - Exclusiv Simina Tănăsescu, despre anularea alegerilor, pensiile magistraților, rolurile și relațiile dintre judecătorii CCR - Interviu video (SpotMedia) - Miliardele SAFE și securitatea de apartament. Cum a ajuns o firmă fără angajați din Râșnov să declare că produce drone militare (PressOne) Ecuația bugetului se complică: Economii de 2,2 miliarde lei, cât costă pachetul de relansare economică, în pericol după ce reforma administrativă a fost atacată la CCR de Avocatul Poporului / PSD insistă și cu măsurile de solidaritate de 3,4 miliarde lei / Ședință a coaliției luni, după o săptămână de tensiuni (G4Media) Liderii coaliției de guvernare se reunesc, luni de la ora 13.00, într-o ședință în care urmează să discute din nou despre bugetul de stat pe acest an, potrivit surselor G4Media. Ședința coaliției este precedată, luni dimineață, de o ședință a conducerii PSD. După o săptămână în care tensiunile dintre PSD și PNL s-au acutizat pe tema bugetului, obținerea unui acord în acest moment pare și mai dificilă, în condițiile în care Avocatul Poporului, Renate Weber, a atacat la Curtea Constituțională ordonanța de urgență care prevede tăieri de cheltuieli de 10% în administrație. Proiectul de buget – care ar fi trebuit adoptat de la finalul anului trecut – a fost amânat atât de mult tocmai pentru că a durat ca PSD să accepte reforma în administrație. Partidele din coaliție au ajuns cu greu la un acord de a face reforma administrativă care pevede tăierea cu 10% a cheltuielilor din administrație, concomitent cu realizarea unui pachet de relansare economică, acesta din urmă presupunând cheltuieli. Cele două pachete au fost adoptate simultan prin ordonanțe de urgență la finalul lunii februarie, iar efectele celor două tipuri de măsuri s-ar fi compensat reciproc în buget: 2,2 miliarde de lei s-ar fi economisit prin reforma administrativă, tot 2,2 miliarde de lei costă măsurile de relansare economică. Însă, odată ce Renate Weber a atacat la CCR reforma administrativă, reducerile de cheltuieli nu mai sunt garantate până când nu se pronunță Curtea Constituțională. Deocamdată nu a fost fixat un termen pentru dezbaterea la Curte a sesizării Avocatului Poporului.  Cine l-a răpit pe Nicușor Dan. O cronologie (Republica) - 17 februarie. Președintele Nicușor Dan se întâlnește la Palatul Cotroceni cu liderii Coaliției ca să discute „mai multe probleme de actualitate”.  - 18 februarie. Sorin Grindeanu a ținut să anunțe primul, cu o jumătate de oră înainte de anunțarea deciziei CCR, că s-a decis deblocarea reformei pensiilor speciale. - 2 martie. Ministrul Justiției Radu Marinescu face propunerile pentru conducerea Parchetelor, propuneri considerate de o parte a societății civile ca fiind „antireformiste”. - 6 martie. Nicușor Dan le spune protestatarilor de la Palatul Cotroceni o frază care-i va marca probabil mandatul: „Am de 100 de ori mai multe informații decât dvs”. Președintele Dan dă de înțeles, cu o surprinzătoare aroganță cu iz pesedist, că va accepta procurorii aleși de PSD, chiar dacă asta va însemna despărțirea sa de propriii alegători. Jurnalistul Florin Negruțiu, co-fondator Republica, a reamintit această cronologie ca să înțelegem că întotdeauna în politică este „ceva pentru ceva”. Nicușor Dan - un președinte fără partid și fără structuri de putere în spate - trebuie să negocieze cu PSD aproape fiecare pas pe care îl face. PSD, partidul acesta care face azi cea mai toxică și mai antinațională politică, sabotând orice încercare de modernizare a țării doar ca să-și conserve puterea acumulată în peste trei decenii, este unde este pentru că a fost votat de mulți oameni. Probabil aceiași oameni care declară la fiecare sondaj că „țara se îndreaptă într-o direcție greșită”, dar care conservă cu votul lor puterea acestei oligarhii care decide direcția țării. Exclusiv Simina Tănăsescu, despre anularea alegerilor, pensiile magistraților, rolurile și relațiile dintre judecătorii CCR - Interviu video (SpotMedia) Judecătoarea Simina Tănăsescu are 57 de ani și a preluat conducerea Curții Constituționale la jumătatea anului trecut. Și-a propus să umanizeze și să sporească încrederea opiniei publice în instituție.  Cu o experiență vastă în magistratură, profesor universitar al Facultății de Drept, fost consilier prezidențial, judecătoarea Tănăsescu este conștientă de importanța deciziilor CCR și susține că instituția trebuie să fie rezervată, să-și asume doar rolul de verificare a constituționalității legilor și nu de arbitru între puterile statului. Anularea alegerilor prezidențiale nu a fost o hotărâre pe care să o fi luat cu ușurință. Nu ne-am gândit că ne-am putea confrunta cu o astfel de situație. Este o hotărâre luată cu unanimitate, asumată și argumentată, bazată pe niște argumente juridice. În ceea ce privește decizia de constituționalitate pentru legea pensiilor magistraților, Curtea Constituțională a verificat compatibilitatea cu Constituția a unei legi. A unei legi care nu vizează nici funcționarea în ansamblu a justiției, nici măcar toate elementele de statut ale profesiei de magistrat – profesie extrem de remarcabilă, onorantă și meritorie – ci un amănunt, un aspect, un detaliu. Acest aspect a mai fost vizat și de alte acte normative, dintre care pe unele Curtea le-a declarat constituționale, pe altele neconstituționale. Interviul integral pe pagina SpotMedia. Miliardele SAFE și securitatea de apartament. Cum a ajuns o firmă fără angajați din Râșnov să declare că produce drone militare (PressOne) La doar o lună după lansarea programului european SAFE – un fond de 150 de miliarde de euro destinat înarmării, din care României îi revin 16,6 miliarde –, o firmă obscură din Râșnov, județul Brașov, fără angajați și fără activitate industrială declarată, își schimbă obiectul de activitate în fabricare de aeronave și nave spațiale militare. Pe scurt, drone militare.  Compania IntellDrones, înființată în 2024, se ocupă, potrivit actelor firmei, de importul de drone agricole din China și oferă servicii de stropire a terenurilor, dar proprietara și administratoarea firmei spune că intenționează să înceapă producția de drone militare „în câteva luni”, scrie PressOne. IntellDrones este deținută și condusă de Ioana-Hermina Păiuș, fostă administratoare a unui fast-food din Râșnov, dar și fostă membră a Partidului Național Liberal. Familia Păiuș are o legătură indirectă de rudenie cu familia liberalului Adrian Veștea, președintele Consiliului Județean Brașov.  Începând cu 2020, Ioana Păiuș urmează trei programe de master cu specializare în studii de securitate și relații internaționale, unul dintre ele la Academia Națională de Informații din subordinea Serviciului Român de Informații (SRI), și începe un doctorat în aceleași domeniu la Universitatea „Babeș-Bolyai” din Cluj-Napoca.  Aceasta apare frecvent în ultimii ani în compania lui Sorin Dobîrcianu, fost ofițer SRI condamnat definitiv de Tribunalul Prahova la trei ani de închisoare cu suspendare pentru trafic de influență. Dobîrcianu, care se recomandă „influencer NATO”, s-a întâlnit în Rusia, la circa o lună după adoptarea programului SAFE, cu un oligarh aflat în cercul direct de influență a lui Vladimir Putin.  

O mercado agro não para e a sua atualização semanal chegou! O Prosa da Semana é o seu ponto de encontro para entender como a safra brasileira está se desenvolvendo. Aqui, transformamos os relatórios semanais das principais instituições em inteligência estratégica, conectando os dados oficiais com a realidade prática do setor.Neste episódio, analisamos os números mais recentes do IMEA, CONAB e CEPEA. Entenda o que os novos boletins revelam sobre o progresso das culturas, o ritmo da colheita e as tendências de preços que estão moldando o cenário atual.Por que ouvir este episódio agora?Acompanhamento Real: Veja a evolução detalhada da safra na última semana.Dados de Autoridade: O resumo técnico do IMEA, CONAB e CEPEA direto ao ponto.Segurança na Decisão: A informação essencial que o profissional do agro precisa para se posicionar no mercado.Não perca tempo cruzando dezenas de tabelas. Dê o play e saia atualizado em poucos minutos com quem analisa o setor de verdade.CONAB: ⁠https://www.gov.br/conab/pt-br⁠CEPEA: ⁠https://cepea.org.br/br⁠Acompanhe os bastidores e atualizações diárias:Instagram: ⁠@cassianoagro⁠ | ⁠@agrodepende⁠Sobre o Prosa da Semana:Seu ponto de encontro semanal para sair atualizado sobre as grandes culturas e o agronegócio no Brasil. Informação direta, técnica e essencial para quem vive o agro.#Agronegocio #Safra2026 #Soja #Milho #EconomiaAgro #CONAB #CEPEA #ProsaDaSemana

Durante el espacio informativo de Ucomur en Onda Regional, Juan Antonio Pedreño anunció la celebración de la Asamblea General ordinaria de UCOERM, señalando que la prioridad para este año es "trabajar hacia dentro" para mejorar la competitividad y las competencias profesionales del profesorado mediante formación especializada. Entre las demandas clave dirigidas a la Consejería de Educación, la organización subraya la urgencia de actualizar el módulo educativo, el cual lleva unos 15 años sin revisarse, además de solicitar un incremento en las horas de orientación y la equiparación de condiciones, como la reducción de la jornada lectiva y la recuperación de ratios, con la escuela pública. De forma paralela, se destacaron iniciativas de éxito como las recientes jornadas sobre economía circular y valores cooperativos, donde se presentaron proyectos escolares de compostaje y reciclaje textil que buscan inculcar la sostenibilidad desde las aulas. María Isabel Nicolás, de la cooperativa Herma, destaca la importancia de los valores cooperativos como una propuesta pedagógica transformadora que sitúa al alumno como el protagonista activo de su propio aprendizaje

Nesta edição especial da Prescrição Cultural em celebração ao Dia Internacional da Mulher, exploramos narrativas de liderança feminina, resiliência e a capacidade de enfrentar pressão em ambientes complexos. A curadoria destaca a trajetória de superação de Michelle Obama no livro Becoming, a excelência técnica das matemáticas da NASA no filme Hidden Figures e a mensagem de autonomia contemporânea na canção Flowers, de Miley Cyrus. Acompanhe estas histórias que celebram o talento e a visão capazes de redefinir instituições e inspirar novas gerações no seu podcast diário de atualização, com curadoria médica e produzido por IA.Afya News. Informação médica confiável e atualizada no seu tempo.Fontes do episódio aqui:⁠https://portal.afya.com.br/podcasts/afya-news/08-03-2026

O balanço desta semana destaca o fortalecimento estrutural do sistema de saúde brasileiro, com a capacitação nacional para gestão de emergências e investimentos de 122 milhões de reais em terapias avançadas para a Atrofia Muscular Espinhal (AME). No campo da assistência, analisamos como o sequenciamento do exoma no SUS está a reduzir o tempo de diagnóstico de doenças raras e a importância de estratégias integradas na prevenção do câncer colorretal. Abordamos ainda a nova resolução do CFM sobre o uso de Inteligência Artificial na medicina e o papel das evidências científicas na atualização constante da prática clínica. Acompanhe a síntese dos factos que impulsionam a autonomia tecnológica e a segurança no cuidado no seu podcast diário de atualização, com curadoria médica e produzido por IA.Afya News. Informação médica confiável e atualizada no seu tempo.Fontes do episódio aqui:⁠https://portal.afya.com.br/podcasts/afya-news/07-03-2026

Inima noastră bate în trei ritmuri esențiale — cel biologic, cel al credinței și cel al tradiției — iar oprirea oricăruia dintre ele ne pune existența în pericol. Trăim într-o eră a vitezei și a tehnologiei care, de multe ori, ne fură timpul și ne blochează creativitatea, devenind un „virus” al lăcomiei care ne îndepărtează de esență. În acest context, întoarcerea către rădăcini, către acel sat românesc care ne-a crescut, nu este un pas înapoi, ci o salvare a propriei noastre umanități. Munca cu mâinile, cum este olăritul sau reabilitarea caselor vechi, ne oferă acea predictibilitate și vizibilitate palpabilă pe care lumea abstractă a corporațiilor nu le poate oferi. Fiecare obiect făurit cu dragoste și rânduială poartă în el amprenta vocală și sufletul autorului, demonstrând că vibrația și intenția contează mai mult decât eficiența pur comercială. Satul nu este doar o locație geografică, ci o stare de spirit în care timpul curge mai lent și unde lucrurile simple — a mânca organic, a te bucura de liniște — sunt adevărata avere. În final, secretul unei vieți împlinite nu stă în acumulare, ci în capacitatea de a rămâne „ciudatul” care păstrează vie rânduiala și omenia, într-o lume care a uitat să se mai respecte. IGDLCC înseamnă Informații Gratis despre Lucruri care Costă! Totul ne costă dar mai ales timpul așa că am făcut această serie pentru a mă informa și educa alături de invitați din domeniile mele de interes. Te invit alături de mine în această călătorie. Mi-am propus să mă facă mai informat și mai adaptat la schimbările care vin. Sper să o facă și pentru tine.

Los carburantes siguen subiendo de precio y para los que trabajan en la carretera esto les supone pérdidas. Los transportistas aseguran que las petroleras tratan de sacar rédito antes de tiempo y piden medidas de contención al Gobierno. Los altos costes se están comiendo ya los beneficios de los transportistas: "El sector esta semana está haciendo viajes en pérdidas", aseguran. Informa Íñigo Tobes.Carlos Folchi, presidente de Fenadismer (Federación Nacional de Asociaciones de Transporte de España), asegura que para los autónomos y pequeñas empresas del sector es muy difícil asumir esta subidas "abusivas" de los precios del combustible. El presidente de Fenadismer cree que las petroleras están sacando rédito a esta situación: "Se produce el efecto pluma con el precio del combustible". Exige al Gobierno que adopte medidas sobre la fiscalidad del combustible y asegura que, de lo contrario, podría estar en peligro la cadena de distribución: "Es urgente que el Gobierno tome medidas". Confían que en la próxima semana se produzca esta reunión con el Gobierno, asegura Folchi, que recuerda que el transporte de mercancías por carretera es un servicio esencial. Entrevista completa en RNE Audio.Escuchar audio

Jornalismo e reflexões sobre a Fórmula 1. Para apoiar o nosso projeto, basta se tornar membro do canal e curtir as premiações: https://www.youtube.com/channel/UCXeOto3gOwQiUuFPZOQiXLA/join   Se preferir um formato diferente de Apoio, confira as facilidades do http://www.apoia.se/cafecomvelocidade para ajudar o Café a crescer e se manter no ar.   E se você curte a agilidade e rapidez do PIX, você pode se tornar apoiador através da chave cafecomvelocidade@gmail.com (este também é o nosso endereço para contato)   APOIANDO O CAFÉ VOCÊ RECEBE: Faixa Café com Leite - Acesso a um grupo exclusivo de membros do canal no whatsapp Faixa Capuccino - O mesmo benefício + acesso a LIVES Exclusivas toda terça-feira pós GP de Fórmula 1 Faixa Extra Forte - Os mesmos benefícios + concorre em sorteios de assinaturas da F1TV até o FINAL DE 2026 ! Faixa Premium - Os mesmos benefícios + concorre também a miniaturas de F1, acesso ao grupo Premium, pode PARTICIPAR das LIVES Exclusivas  e concorre a ingressos para o GP do Brasil de F1 de 2026 em Interlagos !   Não deixe de nos seguir no X / Twitter (@cafevelocidade) e no Instagram (@cafe_com_velocidade)  Siga nossa equipe no X / Twitter: @brunoaleixo80 e @camposfb   Conheça a Noovamais: mais do que uma corretora, uma revolução no mercado de seguros e financiamentos! Acesse www.noovamais.com.br e confira também no Insta @NoovaMais #formula1  #f1 #f12026 #australiangp  #australiangrandprix  #ausgp  #australia  #gpaustralia #f1testing #f1team #f1teams #f1season #f1speed  #abudhabigp #abudhabigrandprix  #abudhabi #gpabudhabi #qatargp  #qatargrandprix #gpqatar  #lasvegasgp #lasvegasgrandprix #lasvegas #braziliangp #saopaulogp #interlagos #gpdobrasil #brazil #mexicogp #méxico #gpmexico #gpdomexico #usgp  #austingp  #singaporegp #singaporegrandprix  #singapore #azerbaijangp #bakugp #gpazerbaijão #italiangp #italiangrandprix #gpitalia #monzacircuit #dutchgp #dutchgrandprix #zandvoort #zandvoortgp #gpholanda  #hungariangp #hungaroring #gphungria   #belgiumgp  #spafrancorchamps #gpbelgica  #britishgp  #britishgrandprix  #british #silverstone #inglaterra   #austriangp  #austria #gpaustria  #canadiangp  #canadiangrandprix #canada #gpcanada  #spanishgp  #spain  #gpdaespanha  #monacogp   #monaco  #gpmonaco  #emiliaromagnagp #imolagp #imola #gpimola  #miamigp #miami #gpmiami  #saudiarabiangp  #saudiarabia #gparabiasaudita  #bahraingp #bahraingrandprix #bahrain #gpbahrain #gpbahrein  #japanesegp #japangp #japão #gpjapão  #chinesegp  #gpchina  #f1testing  #noticiasdaf1 #formulaone  #f1today  #f1tv #f1team  #f1teams  #f1agora  #f1brasil  #preseason2025  #ferrari  #mercedes  #redbull  #redbullracing  #lewishamilton  #maxverstappen  #charlesleclerc  #carlossainz  #fernandoalonso  #mclaren  #landonorris  #oscarpiastri  #georgerussell   #podcast  #podcasts  #podcasting  #automobilismo  #raceweekend  #raceweek  #f12024 #formula12024  #f1news  #f12025 #alpine #alpinef1 #f1motorsport #f1moments #f1movie   0:00  Seja bem vindo ao ALÉM DA VELOCIDADE 7:32  As perguntas que a Fórmula 1 2026 vai responder 12:45  Como as corridas da F1 serão "vendidas" ao público? 22:40  Informações valiosas da situação da Aston Martin ! 37:41  Análise: zonas de abertura de asa e botão Overtake 49:41  Preocupações dos fãs antes do início em Melbourne 58:03  Pode haver disputa interna na Mercedes pelo título ? 1:02:46  Williams e o começo de temporada preocupante

Esta edição apresenta o início da capacitação de profissionais das 27 unidades federativas para a gestão de emergências em saúde pública no SUS, visando respostas mais rápidas e coordenadas a surtos e desastres. O boletim detalha a republicação da Nota Técnica 03/2026 da Anvisa, que atualiza os critérios diagnósticos para Infecções Relacionadas à Assistência à Saúde (IRAS) de notificação nacional obrigatória. Destacamos também o lançamento de uma plataforma da Amazon baseada em IA para automatizar tarefas administrativas, como agendamentos e autorizações, reduzindo a fricção nos fluxos de backoffice hospitalar. Acompanhe as atualizações que fortalecem a resiliência do sistema e a eficiência operacional no seu podcast diário de atualização, com curadoria médica e produzido por IA. Afya News. Informação médica confiável e atualizada no seu tempo.Fontes do episódio aqui:⁠https://portal.afya.com.br/podcasts/afya-news/06-03-2026

Prepare-se para a segunda metade do dia sabendo de tudo que mexeu com o mercado nas primeiras horas do pregão. Informação e análise com Roberto Motta. O Resumo da Manhã é transmitido de segunda a sexta, às 13h. Ative as notificações do programa e acompanhe ao vivo!

⁠⁠⁠Enio Augusto⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ e ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Marcos Buosi⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ falam sobre tudo que envolve o mundo dos tênis e também de outros acessórios relacionados à corrida.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠SEJA MEMBRO DO CANAL!!!⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Aqui tem análises, reviews, dicas, palpites, perguntas, respostas, números, valores e opinião. Informação com bom humor, dúvidas com resposta e conteúdo de sobra. Envie sua pergunta. Escute, aprenda, ensine e divirta-se com a gente.-Os tênis dos atletas no pódio da Maratona de Tóquio 2026.O que são os ultra tênis?Eles são para todo mundo?Vale a pena ter um ultra tênis?-Cupom de Desconto:⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠CORRA BARATO⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ - PFC⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠KEEP RUNNING BRASIL⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ - PFC

Esta edição destaca o investimento de 122 milhões de reais anunciado pelo Ministério da Saúde para o desenvolvimento, na Fiocruz, de uma terapia gênica inovadora voltada à Atrofia Muscular Espinhal (AME). O aporte viabiliza o primeiro estudo clínico desta natureza no Brasil, fortalecendo a autonomia científica e a produção nacional de medicamentos de precisão. Abordamos também a renovação da cobertura de telemedicina pelo Medicare por mais dois anos nos Estados Unidos, consolidando a tendência global de modelos híbridos de assistência. Por fim, apresentamos a transição da inteligência artificial para uma fase de aplicação prática com impacto operacional real, migrando de projetos experimentais para a automação de tarefas e suporte estruturado à decisão clínica. Acompanhe as notícias que impulsionam a inovação e a eficiência na saúde no seu podcast diário de atualização, com curadoria médica e produzido por IA.Afya News. Informação médica confiável e atualizada no seu tempo.Fontes do episódio aqui:⁠https://portal.afya.com.br/podcasts/afya-news/05-03-2026

Prepare-se para a segunda metade do dia sabendo de tudo que mexeu com o mercado nas primeiras horas do pregão. Informação e análise com Roberto Motta. O Resumo da Manhã é transmitido de segunda a sexta, às 13h. Ative as notificações do programa e acompanhe ao vivo!

A defesa de Daniel Vorcaro utilizou dados sigilosos do inquérito conduzido pela Polícia Federal contra o Banco Master para embasar um pedido na Justiça Federal, segundo o jornal O Globo.Madeleine Lascko, Duda Teixeira e Carlos Graieb comentam. Papo Antagonista é o programa que explica e debate os principais acontecimentos do   dia com análises críticas e aprofundadas sobre a política brasileira e seus bastidores.     Apresentado por Madeleine Lacsko, o programa traz contexto e opinião sobre os temas mais quentes da atualidade.     Com foco em jornalismo, eleições e debate, é um espaço essencial para quem busca informação de qualidade.     Ao vivo de segunda a sexta-feira às 18h.    Apoie o jornalismo independente. Assine O Antagonista e Crusoé com 10% via Pix ou Google Pay:   https://assine.oantagonista.com.br/  Siga O Antagonista no X:  https://x.com/o_antagonista   Acompanhe O Antagonista no canal do WhatsApp. Boletins diários, conteúdos exclusivos em vídeo e muito mais.  https://whatsapp.com/channel/0029Va2SurQHLHQbI5yJN344  Leia mais em www.oantagonista.com.br | www.crusoe.com.br #Vorcaro #Investigação #Escandalo #PoliticaBrasileira #Urgente

O boletim de hoje destaca o Mês de Conscientização do Câncer Colorretal, reforçando que a prevenção eficaz combina o rastreamento por colonoscopia com mudanças no estilo de vida e educação sobre fatores de risco. Apresentamos a nova política do Ministério da Saúde que inclui o sequenciamento completo do exoma no SUS, reduzindo a jornada diagnóstica de doenças raras de sete anos para apenas seis meses. Por fim, abordamos os avanços da "Neurocirurgia 4.0" no Brasil, com o uso de IA e realidade estendida para suporte clínico em regiões remotas e treinamento especializado. Acompanhe as notícias que aceleram o diagnóstico e democratizam a tecnologia na saúde no seu podcast diário de atualização, com curadoria médica e produzido por IA.Afya News. Informação médica confiável e atualizada no seu tempo.Fontes do episódio aqui:⁠https://portal.afya.com.br/podcasts/afya-news/04-03-2026

Prepare-se para a segunda metade do dia sabendo de tudo que mexeu com o mercado nas primeiras horas do pregão. Informação e análise com Roberto Motta. O Resumo da Manhã é transmitido de segunda a sexta, às 13h. Ative as notificações do programa e acompanhe ao vivo!

Integrarea europeană a Republicii Moldova se negociază la Bruxelles, dar se construiește în primării. La București, la Green Energy Expo, 50 de primari din Republica Moldova au participat la o conferință comună cu primarii din România. O absență notabilă de la conferința primarilor de la București a fost cea a unei delegații a Primăriei Chișinău. Primarul Ion Ceban are interzis în UE după ce a fost declarat persoana non-grata de statul român, care l-a calificat drept amenințare pentru securitatea națională din cauza legăturilor sale cu Rusia. Mădălina Șerban aduce detalii. Iată temele ediției: - Se fac 4 ani de la momentul în care Republica Moldova a depus cererea de aderare la Uniunea Europeană. În 2022, într-un context regional extrem de dificil, la nici două săptămâni de la declanșarea agresiunii Rusiei în Ucraina, Chișinăul decidea să rupă ambiguitatea geopolitică în care s-a complăcut decenii la rând, când a încercat să se împace și cu estul, și cu vestul și a tranșat clar opțiunea sa de viitor. O corespondență de Valeria Vițu. - Lecție despre cum să falsifici istoria: administrația separatistă de la Tiraspol a lansat o campanie în care explică separatismul din stânga Nistrului. Republica Moldova este numită fie stat artificial, fie atunci când este menționată Basarabia, se vorbește despre o colonie a României. A urmărit campania separatistă Vitalie Cojocari și ne prezintă detalii în „Cronica lui Vitalie”. - Invitatul Moldova Zoom de astăzi este Alexandru Postică, reprezentant al Asociației Foștilor Deportați și Deținuți Politici, care spune că Republica Moldova are nevoie de o instituție națională dedicată culturii memoriei. Autoritățile și societatea civilă anunță inițierea unui Muzeu al Memoriei și Analizei Războiului de pe Nistru din 1992. Un interviu realizat la Chișinău de Liliana Barbăroșie. - Guvernul de la Chișinău declară stare de alertă în sectorul energetic. Anunțul a fost făcut de premierul Alexandru Munteanu. - Mai mulți cetățeni ai Republicii Moldova au solicitat evacuarea din Orientul Mijlociu. - Republica Moldova marchează în martie Zilele Francofoniei, printr-un program amplu de activități culturale, academice și educaționale. Știrile zilei: Guvernul de la Chișinău declară stare de alertă în sectorul energetic pentru 60 de zile. Măsura vine în contextul evoluțiilor recente din Orientul Mijlociu, impactul economic, inclusiv evoluția prețurilor. Anunțul a fost făcut acum câteva minute de premierul Alexandru Munteanu în deschiderea ședinței Executivului. *** Mai mulți cetățeni ai Republicii Moldova aflați în Orientul Mijlociu au solicitat evacuarea. Ministerul Afacerilor Externe anunță că monitorizează permanent evoluțiile prin intermediul Celulei de Criză și menține legătura cu misiunile diplomatice din statele vizate. Două persoane au fost evaluate din Israel, cu sprijinul României. Trimiterile poștale internaționale către mai multe state din Orientul Mijlociu vor fi sistate pentru o perioadă nedeterminată, din cauza suspendării traficului aerian. Măsura vizează scrisorile și coletele destinate Israelului, Irakului, Arabiei Saudite, Emiratelor Arabe Unite, Libanului, Iordaniei, Qatarului și Bahrainului. *** Fostul număr doi din serviciul de informații al Republicii Moldova, Alexandru Bălan, arestat în România pentru colaborare cu serviciile secrete din Belarus, folosea metode clasice de spionaj adaptate erei digitale și trimitea sistematic rapoarte scrise în rusă. La scurt timp după arestarea sa, unul din conturile de poștă electronică pe car ele folosea a fost șters de pe o adresă IP din Belarus, scrie Digi24. Publicația notează că dosarul lui Alexandru Bălan ridică întrebări grave despre vulnerabilitățile structurale ale serviciilor de informații din Republica Moldova și despre amploarea penetrării acestora de către servicii ostile. Arestat în România pentru divulgarea secretului care periclitează securitatea națională, Alexandru Bălan a fost trimis în judecată la finalul săptămânii trecute, fiind acuzat oficial de tentativă la trădare prin transmitere de informații secrete de stat. Dosarul instrumentat de DIICOT se va judeca la Curtea de Apel București. Alexandru Bălan a fi ajuns adjunct al șefului Serviciului de Informații și Securitate de la Chișinău în 2016, cu ajutorul oligarhului Vladimir Plahotniuc. *** Pentru a restabili legătura de transport cu satele moldovenești din regiunea transnistreană, circulație care poate fi făcută doar cu bacul peste râul Nistru, autoritățile au efectuat lucrări de spargere a gheții. Bacul Molovata urmează să-și reia activitatea, după o pauză de două luni, după ce râul Nistru a înghețat din cauza gerului puternic din ianuarie. În lipsa bacului, aprovizionarea localităților, dar și circulația localnicilor se face rutier prin posturile de control ale administrației separatiste transnistrene, rută considerată nesigură.   Într-un mesaj public, administrația bacului a atras atenția asupra pericolului pe care îl prezintă gheața în această perioadă. Aceasta a devenit instabilă și prezintă un risc sporit pentru pescari și persoanele care se află în apropierea apei. Autoritățile urmează să anunțe data la care circulația bacului de la Molovata va fi reluată în regim normal. *** Republica Moldova marchează în martie Zilele Francofoniei, printr-un program amplu de activități culturale, academice și educaționale desfășurate la nivel național. Evenimentele reunesc instituții de învățământ, organizații culturale și misiuni diplomatice, anunță Radio Chișinău. Programul include conferințe, dezbateri, concursuri academice, proiecții de film, spectacole de teatru, recitaluri de poezie, ateliere tematice și competiții lingvistice. Activitățile sunt organizate la Chișinău, Bălți, Tiraspol, Cahul, Ungheni, Orhei, Soroca, Hâncești și în alte localități din R. Moldova. Un punct important al programului este cea de-a 25-a ediție a Festivalului Filmului Francofon, care se va desfășura în a doua jumătate a lunii martie.

Industrial Talk is onsite at MD&M West and talking to Adrienne Zepeda, VP, Growth Portfolio Lead at Informa Markets about "Manufacturing, a community built on connections". The conversation highlights the success and impact of the MD&M West event, organized by Informa. Adrienne Zepeda, Vice President at Informa, discusses the event's significance, noting over 12,000 attendees and the extensive planning involved, starting two to four weeks post-event. Adrienne emphasizes the importance of continuous improvement, leveraging feedback from exhibitors and attendees, and planning events up to two years in advance. Despite challenges, such as COVID-19, the event maintained its schedule, showcasing innovative technologies and fostering human connections. Adrienne's role involves overseeing six events, including MD&M West, and ensuring the success of each event through meticulous planning and collaboration. Outline MD&M West Event Overview and Introduction Industrial Talk, sponsored by MD&M West and News and Brews, highlighting the event's focus on medtech automation, packaging, plastics, and design.Scott emphasizes the importance of attending MD&M West, describing it as a significant event for manufacturers solving market challenges.Scott mentions the involvement of Informa in organizing MD&M West and introduces Adrienne Zepeda, a professional from Informa, to discuss the event's details. Adrienne Zepeda's Role and Event Planning Scott and Adrienne discuss the scale of MD&M West, with over 12,000 attendees and still one more day to go.Adrienne explains the extensive planning involved in organizing the event, starting as early as two to four weeks after the current event.Adrienne shares his background, mentioning his role as Vice President at Informa, overseeing six events, including MD&M West.Adrienne describes the cross-collaborative nature of his team, involving sales, operations, digital marketing, and event technology teams, totaling around 50 to 60 people. Measuring Success and Event Impact Adrienne measures success through feedback from exhibitors and attendees, such as increased booth activity and lead generation.Adrienne highlights the importance of creating experiences that resonate with attendees and provide value throughout the year.Scott and Adrienne discuss the challenges and rewards of organizing such a large-scale event, including the need for continuous planning and improvement.Adrienne shares his personal motivation for organizing the event, focusing on the impact on the industry and the lives of people. Impact of COVID-19 and Event Adaptation Scott inquires about the impact of COVID-19 on MD&M West and the industry's resilience.Adrienne explains that the need for manufacturing products remained constant during the pandemic, allowing the event to continue with some adjustments.The event schedule was adjusted to accommodate the changing circumstances, with shows held in February 2020, August 2021, and April 2022.Adrienne emphasizes the importance of maintaining human connections and the unique value of in-person events. Innovation and Technology at MD&M West Scott and Adrienne discuss the rapid pace of innovation and technology in the manufacturing industry.Adrienne shares his fascination with the industry's continuous advancements and the impact of new technologies on manufacturing processes.Scott highlights specific examples of innovative products and technologies showcased at MD&M West, such as the magnetic maintenance device.The conversation touches on the importance of maintaining a forward-thinking approach to stay ahead of industry trends. Future Plans and Industry Trends Scott asks about Adrienne's plans for the next year and the future of MD&M West.Adrienne expresses excitement about bringing the industry together again and incorporating feedback from surveys and advisory boards into future planning.The discussion includes the importance of adapting to changing industry needs and maintaining a focus on creating valuable experiences for attendees and exhibitors.Scott and Adrienne reflect on the significance of the event in fostering connections and driving innovation in the manufacturing industry. Final Thoughts and Contact Information Scott and Adrienne wrap up the conversation, expressing mutual appreciation for the work done at MD&M West.Adrienne provides contact information for those interested in participating in future events, including the MD&M West website and social media links.Scott encourages listeners to reach out to Adrienne and explore the various events organized by Informa.The episode concludes with a reminder of the importance of attending industry events to build meaningful connections and drive success. If interested in being on the Industrial Talk show, simply contact us and let's have a quick conversation. Finally, get your exclusive free access to the Industrial Academy and a series on “Why You Need To Podcast” for Greater Success in 2026. All links designed for keeping you current in this rapidly changing Industrial Market. Learn! Grow! Enjoy! ADRIENNE ZEPEDA'S CONTACT INFORMATION: Personal LinkedIn: https://www.linkedin.com/in/adriennezepeda/ Company LinkedIn: https://www.linkedin.com/company/informamarketsmanufacturing/ Company Website: https://www.imeeventscalendar.com/ PODCAST VIDEO: https://youtu.be/fPwarC3Xo7g THE STRATEGIC REASON "WHY YOU NEED TO PODCAST": OTHER GREAT INDUSTRIAL RESOURCES: NEOM: https://www.neom.com/en-us Hexagon: https://hexagon.com/ Arduino: https://www.arduino.cc/ Fictiv: https://www.fictiv.com/ Hitachi Vantara: https://www.hitachivantara.com/en-us/home.html Industrial Marketing Solutions:  https://industrialtalk.com/industrial-marketing/ Industrial Academy: https://industrialtalk.com/industrial-academy/ Industrial Dojo: https://industrialtalk.com/industrial_dojo/ We the 15: https://www.wethe15.org/ YOUR INDUSTRIAL DIGITAL TOOLBOX: LifterLMS: Get One Month Free for $1 – https://lifterlms.com/ Active Campaign: Active Campaign Link Social Jukebox: https://www.socialjukebox.com/ Industrial Academy (One Month Free Access And One Free License For Future Industrial Leader): Business Beatitude the Book Do you desire a more joy-filled, deeply-enduring sense of accomplishment and success? Live your business the way you want to live with the BUSINESS BEATITUDES...The Bridge connecting sacrifice to success. YOU NEED THE BUSINESS BEATITUDES! TAP INTO YOUR INDUSTRIAL SOUL, RESERVE YOUR COPY NOW! BE BOLD. BE BRAVE. DARE GREATLY AND CHANGE THE WORLD. GET THE BUSINESS BEATITUDES! Reserve My Copy and My 25% Discount

Educația financiară nu este un moft, ci o necesitate pentru oricine vrea să scape de „bolovanul” banilor blocați în investiții ineficiente și să atingă o prosperitate reală, bazată pe cifre, nu pe iluzii. Într-o piață imobiliară adesea supraevaluată și lipsită de transparență, este esențial să înțelegi diferența dintre prețul cerut de vânzător și valoarea corectă, dictată de randamentul chiriei pe termen lung. Adevărata libertate vine din disciplina de a investi constant, preferând bursa și activele diversificate în locul obsesiei românești pentru proprietate, care deseori îți consumă mai mult de jumătate din venituri. Nu te lăsa condus de lăcomie sau de dorința de a te îmbogăți peste noapte, deoarece cea mai mare păcăleală în viață este să gândești doar de pe azi pe mâine. Strategia mea rămâne neschimbată: investește rațional pentru obiectivele familiei tale, asigurându-te că ai un plan de rezervă care să îți permită să dormi liniștit în fiecare seară. Succesul nu înseamnă să-ți depășești vecinii, ci să ai resursele necesare pentru a oferi aripi copiilor tăi și pentru a-ți asigura un viitor predictibil, indiferent de contextul economic. În final, dincolo de grafice și analize reci, un plan financiar bine pus la punct are la bază mult suflet și dorința sinceră de a construi ceva durabil pentru cei dragi. IGDLCC înseamnă Informații Gratis despre Lucruri care Costă! Totul ne costă dar mai ales timpul așa că am făcut această serie pentru a mă informa și educa alături de invitați din domeniile mele de interes. Te invit alături de mine în această călătorie. Mi-am propus să mă facă mai informat și mai adaptat la schimbările care vin. Sper să o facă și pentru tine.

Toto je zkrácená verze (111 minut). Celý díl (170 minut) a bez reklam si můžeš pustit zde: https://open.spotify.com/episode/73GxGPgb4vfkpwJJ3tcmng?si=ba64a76464584d37Filozofie je pro každého. Je to nástroj svobody.V této epizodě mluvíme s filozofkou Terezou Matějčkovou o tom, proč skutečné myšlení vždy narušuje pohodlí, proč empatie bez nesouhlasu vede k stagnaci a proč odvaha myslet znamená přijmout i vlastní nedostatečnost.Filozofie podle ní není o odpovědích, ale o otázkách, které rozrušují naše jistoty. Je to schopnost ustát selhání, unést samotu a zpochybnit i vlastní kulturu, která nás formovala. V době přecitlivělosti, digitálního tlaku a strachu z ostrakizace je to radikálnější než kdy dřív.Tohle není epizoda o teorii. Je o tom, jak si uchovat vnitřní život, autenticitu a svobodu a to v čase, který miluje rychlé soudy a nenávidí nepohodlné otázky.A je to tady! Znovu pořádáme Brain We Are mini fest, tentokrát jako hosté budou terapeutka a zakladatelka institutu moderní lásky Markéta Šetinová, dále pak prof. Jan Hábl a úžasná a zábavná Chili Ta Thuy, na konec si zase dáme Ecstatic Dance s DJ Martin Karcol.Kupuj lístek zde: https://goout.net/cs/brain-we-are-vztahy-a-smysl-chilli-ta-jan-habl/sztychy/Parťáci dílu:KusKakaa - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.kuskakaa.cz⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠  Přináší do Česka čistá ceremoniální kakaa. A proč si takové kakao dopřát? Ukazuje se, že přináší celou řadu benefitů a má velký obsah flavonoidů a polyfenolů. Tak jdi na ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠www.kuskakaa.cz⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ a zkus jedno z jejich kvalitních kakaí! Doporučujeme to z Kostariky, nebo Peru.Fondee.cz - ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://www.fondee.cz/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ Unikátní platforma na investování v ČR, kterou sami používáme. Navštiv ⁠⁠⁠www.Fondee.cz⁠⁠⁠ a zadej kód "BWA" pro 3 měsíce investování zdarma! Začni třeba už s 1000,- // Investování se pojí s riziky. Minutáž:00:00 Úvod a představení hosta05:17 Filozofie jako nástroj k výchově autonomních bytostí10:44 Distance od světa a důležitost klasického vzdělání15:56 Rozdíl mezi přírodními vědami a filozofií20:49 Sebevědomí, odvaha myslet a schopnost snést selhání25:59 Odchod z akademické sféry a redefinice úspěchu27:01 Empatie v digitálním prostoru32:34 Strach z veřejné kritiky a obranné mechanismy35:40 Citlivost vs. přecitlivělost společnosti43:32 Informační přehlcení a primární odpovědnost k sobě55:29 Návrat k vlastní zkušenosti v technologické době01:01:12 Kognitivní zkratky a nebezpečí nálepkování01:05:25 Hledání vlastního já navzdory očekávání okolí01:10:48 Audience capture a utváření identity01:13:06 Stárnutí jako osvobozující proces01:17:39 Zvládání selhání a ztráty pověsti01:21:23 Technologické zplošťování světa a ztráta autenticity01:28:26 Původ slova autenticita a její skutečný význam01:32:19 Strach z odhalení vlastních slabostí01:38:31 Rozdíl mezi akademickou sférou a veřejným prostorem01:44:51 Riziko ustrnutí ve frázích a struktura sebevědomíPřechod do VIP části- Koncept happychondrie a toxický tlak na štěstí- Nezastupitelná role humanitních věd- Datový absolutismus versus osobní zkušenost- Abstraktní myšlení a psaní jako objevování- Učení se nazpaměť a otevírání myšlení- Filozofie opakování u Kierkegaarda a Hegela- Opakování vpřed a osvobození skrze normy- Kognitivní vědy a přerámování reality- Fenomenologická pozice a limity umělé inteligence- Význam fyzického těla v digitální éře- Význam rozhovorů pro utváření myšlení

O boletim de hoje destaca a entrada em operação do sistema de Identificação Única de Dispositivos Médicos (UDI) da Anvisa, um marco para a rastreabilidade e segurança de insumos como próteses e stents. Trazemos o alerta da OMS sobre a perda auditiva na infância, com orientações práticas para a revisão do rastreio e encaminhamento precoce no consultório. Por fim, abordamos os projetos-piloto no Reino Unido que testam restrições de redes sociais para adolescentes e como isso reflete na demanda clínica por orientação sobre higiene do sono e uso de telas. Acompanhe as notícias que reforçam a segurança do paciente e o desenvolvimento pediátrico no seu podcast diário de atualização, com curadoria médica e produzido por IA.Afya News. Informação médica confiável e atualizada no seu tempo.Fontes do episódio aqui:⁠https://portal.afya.com.br/podcasts/afya-news/03-03-2026

Prepare-se para a segunda metade do dia sabendo de tudo que mexeu com o mercado nas primeiras horas do pregão. Informação e análise com Roberto Motta. O Resumo da Manhã é transmitido de segunda a sexta, às 13h. Ative as notificações do programa e acompanhe ao vivo!

O boletim de hoje destaca a nova Resolução CFM nº 2.454/2026, que estabelece as normas para o uso responsável da inteligência artificial na medicina brasileira, reforçando a autonomia e a supervisão humana obrigatória. Apresentamos a aprovação pelo FDA do Bysanti (milsaperidona) como nova opção terapêutica para esquizofrenia e transtorno bipolar, com alertas importantes sobre segurança e uso em idosos. Por fim, abordamos o avanço nas negociações da OMS para o acordo global contra pandemias, focado na partilha equitativa de patógenos e tecnologias. Acompanhe as atualizações que definem os marcos éticos e regulatórios da sua prática no seu podcast diário de atualização, com curadoria médica e produzido por IA.Afya News. Informação médica confiável e atualizada no seu tempo.Fontes do episódio aqui:⁠https://portal.afya.com.br/podcasts/afya-news/02-03-2026

Prepare-se para a segunda metade do dia sabendo de tudo que mexeu com o mercado nas primeiras horas do pregão. Informação e análise com Roberto Motta. O Resumo da Manhã é transmitido de segunda a sexta, às 13h. Ative as notificações do programa e acompanhe ao vivo!

Nesta edição de domingo, a Prescrição Cultural convida você a dar um passo atrás e olhar para o macro com o best-seller "Sapiens: Uma Breve História", de Yuval Noah Harari. O episódio traz também a sensibilidade do filme "O Filho de Mil Homens", disponível na Netflix , e a profundidade de "Hamnet", que reconstrói o luto e a superação durante tempos de peste. Para fechar com chave de ouro, celebramos o legado geracional de Gilberto Gil na nova temporada do Tiny Desk Brasil. Aproveite este momento de pausa qualificada para expandir seu repertório e renovar as energias no seu podcast diário de atualização, com curadoria médica e produzido por IA.Afya News. Informação médica confiável e atualizada no seu tempo. Fontes do episódio aqui:⁠https://portal.afya.com.br/podcasts/afya-news/01-03-2026

Neste resumo da semana, analisamos o avanço das fronteiras metabólicas, desde a discussão do CFM sobre a linha de cuidado da obesidade no SUS até a promissora molécula "triple G" e a reprogramação de hemácias para o controle glicêmico. O episódio recapitula os alertas críticos de segurança sanitária, como o recolhimento de antibióticos pela Anvisa e o combate a produtos falsificados , além da vigilância contra surtos de coqueluche e influenza pediátrica. Fechamos com o cenário regulatório do ProfiMed no Senado e os novos marcos de integração e financiamento da saúde digital. Acompanhe a síntese dos fatos que exigem atenção técnica e visão estratégica para a sua carreira no seu podcast diário de atualização, com curadoria médica e produzido por IA.Afya News. Informação médica confiável e atualizada no seu tempo.Fontes do episódio aqui:⁠https://portal.afya.com.br/podcasts/afya-news/28-02-2026

O boletim de hoje destaca a determinação da Anvisa para a apreensão de bioestimuladores de colágeno falsificados e as medidas de segurança indispensáveis para a prática de procedimentos. Apresentamos a descoberta de uma nova via terapêutica para o diabetes, onde a hipóxia reprograma as hemácias para atuarem como um "sumidouro" de glicose. Por fim, analisamos o alerta europeu sobre a alta resistência antimicrobiana na cadeia alimentar e a importância da abordagem "One Health". Acompanhe as notícias que reforçam a segurança do paciente e a inovação biológica no seu podcast diário de atualização, com curadoria médica e produzido por IA.Afya News. Informação médica confiável e atualizada no seu tempo.Fontes do episódio aqui:⁠https://portal.afya.com.br/podcasts/afya-news/27-02-2026

Portugal é usado para contornar sanções europeias e o Serviço de Informações de Segurança (SIS) está a vigiar cidadãos russos que investem em Portugal. O Ministério Público abriu vários inquéritos-crime e já congelou 25 milhões de euros. A guerra é na Ucrânia mas tem implicações em todos os países da Europa. Para perceber o que está a acontecer em Portugal, conversamos com o jornalista Hugo Franco.See omnystudio.com/listener for privacy information.

Rezultatul oricărei alegeri mari se bazează pe procesul prin care ajungi la ea, nu doar pe impulsul de moment. Claritatea este atributul esențial al unui lider, fiindcă trebuie să știi exact unde te afli înainte de a decide încotro vrei să mergi. O metodă practică de a structura gândirea este desenarea sistemelor pe hârtie, proces care forțează creierul să conecteze ideile și să elimine confuzia. Deciziile devin automat mai bune atunci când există conștientizarea că mecanismul din spatele lor va trebui explicat și justificat în fața altora. Modestia intelectuală este motorul evoluției, oferind capacitatea de a pune sub semnul întrebării propriile convingeri și de a accepta posibilitatea erorii. Este mult mai dificil procesul de a te dezvăța de idei vechi decât cel de a învăța lucruri noi, dar această agilitate mentală este necesară pentru a rămâne relevant. În final, responsabilitatea unei alegeri este ca o „bombă” care trebuie gestionată prin analiză, ponderarea criteriilor și controlul emoțiilor. IGDLCC înseamnă Informații Gratis despre Lucruri care Costă! Totul ne costă dar mai ales timpul așa că am făcut această serie pentru a mă informa și educa alături de invitați din domeniile mele de interes. Te invit alături de mine în această călătorie. Mi-am propus să mă facă mai informat și mai adaptat la schimbările care vin. Sper să o facă și pentru tine.

O boletim de hoje destaca o alerta de coqueluche no Brasil e no mundo, reforçando a necessidade de alta suspeição clínica diante de casos de tosse persistente. Apresentamos a aprovação pelo FDA do Optune Pax, um dispositivo inovador que utiliza campos elétricos para o tratamento do câncer de pâncreas localmente avançado. Por fim, analisamos o novo marco da OPAS para o fortalecimento das Redes Integradas de Serviços de Saúde nas Américas, visando reduzir a fragmentação do cuidado. Acompanhe as notícias que impactam a vigilância epidemiológica e a inovação tecnológica no seu podcast diário de atualização, com curadoria médica e produzido por IA.Afya News. Informação médica confiável e atualizada no seu tempo.Fontes do episódio aqui:⁠https://portal.afya.com.br/podcasts/afya-news/26-02-2026

⁠⁠⁠Enio Augusto⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ e ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Marcos Buosi⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ falam sobre tudo que envolve o mundo dos tênis e também de outros acessórios relacionados à corrida.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠SEJA MEMBRO DO CANAL!!!⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠Aqui tem análises, reviews, dicas, palpites, perguntas, respostas, números, valores e opinião. Informação com bom humor, dúvidas com resposta e conteúdo de sobra. Envie sua pergunta. Escute, aprenda, ensine e divirta-se com a gente.-Qual tênis você escolheria para ganhar de aniversário?Superblast e Evo SL tem a mesma proposta? Qual é mais “faz tudo”?Alguns dos últimos lançamentos.Puma Deviate Nitro Elite 4.Olympikus Corre Pace.Mizuno Neo Zen 2.Asics Magic Speed 5.New Balance 1080 v15.Fila Speedrocker com a nova espuma Skyfoam.Adidas Supernova Rise 3.Adidas Supernova Glide.-Cupom de Desconto:⁠⁠⁠⁠⁠⁠⁠⁠⁠CORRA BARATO⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ - PFC⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠KEEP RUNNING BRASIL⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠ - PFC

O boletim de hoje destaca a votação no Senado do ProfiMed, o exame nacional que pode se tornar requisito obrigatório para o exercício da medicina no Brasil. Apresentamos como o ultrassom à beira-leito (POCUS) tem superado manobras clássicas do exame físico na confirmação de sobrecarga volêmica. Além disso, analisamos o avanço do UBT251, a nova classe de antiobesidade "Triple G" que promete perdas de peso superiores aos atuais análogos de GLP-1. Acompanhe as notícias que impactam a sua carreira e as inovações que chegam ao consultório no seu podcast diário de atualização, com curadoria médica e produzido por IA. Afya News. Informação médica confiável e atualizada no seu tempo.Fontes do episódio aqui:⁠https://portal.afya.com.br/podcasts/afya-news/25-02-2026

O boletim de hoje destaca a determinação da Anvisa para o recolhimento de um lote do antibiótico Kefadim após a confirmação de um desvio de qualidade na embalagem. Apresentamos também um estudo destacado pela American Heart Association que revela que mulheres com menor volume de placa coronariana possuem risco de eventos cardíacos tão elevado quanto homens, exigindo maior rigor na prevenção clínica. Por fim, abordamos o novo posicionamento da OMS Europa sobre os caminhos de financiamento e evidências para a sustentabilidade da saúde digital. Acompanhe as notícias que reforçam a segurança do paciente e a precisão no manejo cardiovascular no seu podcast diário de atualização, com curadoria médica e produzido por IA.Afya News. Informação médica confiável e atualizada no seu tempo.Fontes do episódio aqui:⁠https://portal.afya.com.br/podcasts/afya-news/24-02-2026

Succesul autentic vine din curajul de a experimenta și de a testa idei noi fără teama de a eșua în fața publicului. Este esențial să ne oprim periodic din agitația zilnică pentru a învăța lucruri noi și pentru a ne verifica sistemul de valori personale. Tehnologia modernă și inteligența artificială trebuie privite ca unelte puternice care ne ajută să ne transformăm viziunile în realitate mult mai rapid decât în trecut. În același timp, educația trebuie să evolueze spre un model personalizat, adaptat nevoilor și ritmului unic al fiecărui individ. Oamenii care au atins succesul au datoria morală de a sprijini comunitatea și de a împărtăși experiența lor celor aflați la început de drum. Societatea ar funcționa mult mai eficient dacă s-ar baza pe competență și pe respectarea cuvântului dat, în locul birocrației rigide. În final, viitorul nostru depinde în mod direct de capacitatea de a rămâne curioși și de a ne adapta constant la schimbările accelerate ale lumii. IGDLCC înseamnă Informații Gratis despre Lucruri care Costă! Totul ne costă dar mai ales timpul așa că am făcut această serie pentru a mă informa și educa alături de invitați din domeniile mele de interes. Te invit alături de mine în această călătorie. Mi-am propus să mă facă mai informat și mai adaptat la schimbările care vin. Sper să o facă și pentru tine.

Experiența noastră subiectivă nu este o reacție directă la realitatea obiectivă, ci o construcție activă a creierului, care editează continuu percepțiile pentru a crea un „film” coerent al lumii. Emoțiile nu sunt mecanisme universale înnăscute sau entități biologice fixe, ci sunt etichete culturale și lingvistice pe care le aplicăm unor senzații fizice de bază, numite interocepție. Acest proces de construcție depinde fundamental de context, educație și mediul social, ceea ce explică de ce culturile non-occidentale pot experimenta stări interne complet diferite de ale noastre. La nivel biologic, sistemul imunitar joacă un rol central în generarea semnalelor pe care le interpretăm drept emoții negative sau alerte de pericol. Sănătatea mentală este strâns legată de „alostază”, procesul predictiv prin care creierul gestionează bugetul de energie al corpului pentru a face față provocărilor viitoare. Atunci când aceste mecanisme de adaptare sunt suprasolicitate sau devin imprevizibile, apare stresul cronic și inflamația, care pot conduce în final la stări precum depresia. În concluzie, suntem sisteme biologice complexe care funcționează optim doar atunci când reușim să menținem un echilibru între predicțiile minții și nevoile energetice ale organismului. IGDLCC înseamnă Informații Gratis despre Lucruri care Costă! Totul ne costă dar mai ales timpul așa că am făcut această serie pentru a mă informa și educa alături de invitați din domeniile mele de interes. Te invit alături de mine în această călătorie. Mi-am propus să mă facă mai informat și mai adaptat la schimbările care vin. Sper să o facă și pentru tine.

Melissa Lavasani & Jay Kopelman join our podcast to discuss how psychedelic policy is actually moving in Washington, DC. Lavasani leads Psychedelic Medicine Coalition, a DC-based advocacy organization focused on educating federal officials and advancing legislation around psychedelic medicine. Kopelman is CEO of Mission Within Foundation, which provides scholarships for veterans and first responders seeking psychedelic-assisted therapy retreats, often outside the United States. The conversation centers on veterans, the VA, and why that system may be the first realistic federal pathway for psychedelic care. Early Themes Lavasani describes PMC's work on Capitol Hill, including hosting events that bring lawmakers, staffers, and advocates into the same room. Her focus is steady engagement. In DC, progress often happens through repeated conversations, not headlines. Kopelman shares his background as a Marine and how his own psychedelic-assisted therapy experience led him to Mission Within. The foundation has funded more than 250 scholarships for veterans and first responders seeking treatment for PTSD, mild traumatic brain injury, depression, and addiction. They connect this work to pending veteran-focused legislation and explain why the VA matters. As a closed health system, the VA can pilot programs, gather data, and refine protocols without the pressures of private healthcare markets. Core Insights A recent Capitol Hill gathering, For Veteran Society, brought together members of Congress and leaders from the psychedelic caucus. Lavasani describes candid feedback from lawmakers. The message was clear: coordinate messaging, avoid fragmentation, and move while bipartisan interest remains. Veteran healthcare is not framed as the final goal. It is a starting point. If psychedelic therapies can demonstrate safety and effectiveness within the VA, broader adoption becomes more plausible. Kopelman raises operational realities that must be addressed: Standardized safety protocols across providers Integration support, not medication alone Clear training pathways for clinicians Real-world data beyond tightly screened clinical trials They also address recent negative headlines involving ibogaine treatment abroad. Kopelman emphasizes the need for shared learning across providers, especially when adverse events occur. Lavasani argues that inconsistency within the ecosystem can slow federal confidence. Later Discussion and Takeaways The discussion widens to federal momentum around addiction and mental health. Lavasani notes that new funding initiatives signal growing openness to innovative treatment models, even if psychedelics are not named explicitly in every announcement. Both guests stress that policy moves slowly by design. Meetings, follow-ups, and relationship building often matter more than public statements. For clinicians, researchers, operators, and advocates, the takeaways are direct: Veterans are likely the first federal pathway Public education remains essential Safety standards must be shared and transparent Integration and workforce development need attention now If psychedelic medicine enters federal systems, infrastructure will determine success. Frequently Asked Questions What do Melissa Lavasani & Jay Kopelman say about VA psychedelic policy? They argue that veteran-focused legislation offers a realistic first federal pathway for psychedelic-assisted care. Is ibogaine currently available through the VA? No. They discuss ibogaine in the context of private retreats and future possibilities, not an existing VA program. Why do Melissa Lavasani & Jay Kopelman emphasize coordination? Lawmakers respond more positively when advocates present aligned messaging and clear priorities. What safety issues are discussed by Melissa Lavasani & Jay Kopelman? They highlight the need for standardized screening, monitoring, integration support, and transparent review of adverse events. Closing Melissa Lavasani & Jay Kopelman provide a grounded look at how psychedelic policy develops inside federal systems. Their message is practical: veterans may be the first lane, but long-term success depends on coordination, safety standards, and sustained engagement. Closing This episode captures a real-time view of how federal policy could shape the next phase of the psychedelic resurgence, especially through veteran-facing legislation and VA infrastructure. Melissa Lavasani & Jay Kopelman argue that coordination, public education, and shared safety standards will shape whether access expands with credibility and care. Transcript Joe Moore: [00:00:00] Hello everybody. Welcome back to Psychedelics Today. Today we have two guests, um, got Melissa Sani from Psychedelic Medicine Coalition. We got Jake Pelman from Mission Within Foundation. We're gonna talk about I bga I became policy on a recent, uh, set of meetings in Washington, DC and, uh, all sorts of other things I'm sure. Joe Moore: But thank you both for joining me. Melissa Lavasani: Thanks for having us. Jay Kopelman: Yeah, it's a pleasure. Thanks. Joe Moore: Yeah. Um, Melissa, I wanna have you, uh, jump in. First. Can you tell us a little bit about, uh, your work and what you do at PMC? Melissa Lavasani: Yeah, so Psychedelic Medicine Coalition is, um, the only DC based Washington DC based advocacy organization dedicated to the advancing the issue of psychedelics, um, and making sure the federal government has the education they need, um, and understands the issue inside out so that they can generate good policy around, around psychedelic medicines. Melissa Lavasani: [00:01:00] Uh, we. Host Hill events. We host other convenings. Our big event every year is the Federal Summit on psychedelic medicine. Um, that's going to be May 14th this year. Um, where we talk about kinda the pressing issues that need to be talked about, uh, with government officials in the room, um, so that we can incrementally move this forward. Melissa Lavasani: Um, our presence here in Washington DC is, is really critical for this issue's success because, um, when we're talking about psychedelic medicines, um, from the federal government pers perspective, you know, they are, they are the ones that are going to initiate the policies that create a healthcare system that can properly facilitate these medicines and make sure, um, patient safety is a priority. Melissa Lavasani: And there's guardrails on this. And, um, you know, there, it's, it's really important that we have. A home base for this issue in Washington DC just [00:02:00] because, uh, this is very complicated as a lot of your viewers probably understand, and, you know, this can get lost in the mix of all the other issues that, um, lawmakers in DC are focused on right now. Melissa Lavasani: And we need to keep that consistent presence here so that this continues to be a priority for members of Congress. Joe Moore: Mm. I love this. And Jay, can you tell us a bit about yourself and mission within Foundation? Jay Kopelman: Yeah, sure. Joe, thanks. Uh, I, I am the CEO of Mission within Foundation. Prior to this, most of my adult life was spent in the military as a Marine. Jay Kopelman: And I came to this. Role after having, uh, a psychedelic assisted therapy experience myself at the mission within down in Mexico, which is where pretty much we all go. Um, we are here to help [00:03:00] provide, uh, access for veterans and first responders to be able to attend psychedelic assisted therapy retreats to treat issues like mild TBI, post-traumatic stress disorder, uh, depression, sometimes addiction at, at a very low level. Jay Kopelman: Um, and, and so we've, we've been doing this for a little more than a year now and have provided 250 plus scholarships to veterans and first responders to be able to access. These retreats and these, these lifesaving medicines. Um, we're also partnered, uh, you may or may not know with Melissa at Psychedelic Medicine Coalition to help advance education and policy, specifically the innovative, uh, therapy Centers of Excellence Act [00:04:00] that Melissa has worked for a number of years on now to bring to both Houses of Congress. Joe Moore: Thank you for that. Um, so let's chat a little bit about what this event was that just, uh, went down, uh, what, what was it two weeks ago at this point? Melissa Lavasani: Yeah. Yeah. It's called For Veteran Society and it's all, um, there's a lot of dialogue on Capitol Hill about veterans healthcare and psychedelics, but where I've been frustrated is that, you know, it was just a lot of. Melissa Lavasani: Talk about what the problems are and not a lot of talk about like how we actually propel things forward. Um, so it, at that event, I thought it was really important and we had three members of Congress there, um, Morgan Latrell, who has been a champion from day one and his time in Congress, um, having gone through the experience himself, um, [00:05:00] at Mission within, um, and then the two chairs of the psychedelic caucus, uh, Lou Correa and Jack Bergman. Melissa Lavasani: And we really got down to the nitty gritty of like w like why this has taken so long and you know, what is actually happening right now? What are the possibilities and what the roadblocks are. And it was, I thought it was a great conversation. Um, we had an interesting kind of dynamic with Latres is like a very passionate about this issue in particular. Melissa Lavasani: Um, I think it was, I think it was really. A great event. And, you know, two days later, Jack Bergman introduced his new bill for the va. Um, so it was kind of like the precursor to that bill getting introduced. And we're just excited for more and more conversations about how the government can gently guide this issue to success. Joe Moore: Hmm. Yeah. [00:06:00] That's fantastic. Um, yeah, I was a little bummed I couldn't make it, but next time, I hope. But I've heard a lot of good things and, um, it's, it sounded like there was some really important messages in, in terms of like feedback from legislators. Yeah. Yeah. Could you speak to that? Melissa Lavasani: Yeah, I mean, I think when, uh, representative Latrell was speaking, he really impressed on us a couple things. Melissa Lavasani: Um, first is that, you know, they really kind of need the advocates to. Coordinate, collaborate and come up with like a, a strategic plan, you know, without public education. Um, talking to members of Congress about this issue is, is really difficult. You know, like PMC is just one organization. We're very little mission within, very little, um, you know, we're all like, kind of new in navigating, um, this not so new issue, but new to Washington DC [00:07:00] issue. Melissa Lavasani: Um, without that public education as a baseline, uh, it's, it's, you have to spend a lot of time educating members of Congress. You know, that's like one of our things is, you know, we have to, we don't wanna tell Congress what direction to go to. We wanna provide them the information so they understand it very intimately and know how to navigate through things. Melissa Lavasani: Um, and secondly. Um, he got pretty frank with us and said, you know, we've got one cha one chance at this issue. And it's like, that's, that's kind of been like my talking point since I started. PMC is like, you have a very limited window, um, when these kind of issues pop up and they're new and they're fresh and you have a lot of the veteran community coming out and talking about it. Melissa Lavasani: And there's a lot of energy there. But now is the time to really move forward, um, with some real legislation that can be impactful. Um, but, you know, we've gotta [00:08:00] be careful. We, we forget, I think sometimes those of us who are in the ecosystem forget that our level of knowledge about these medicines and a lot of us have firsthand experience, um, with these drugs and, and our own healing journeys is, um, we forget that there is a public out there that doesn't have the level of knowledge that we all have. Melissa Lavasani: And, um. We gotta make sure that we're sticking to the right elements of, of, of what needs to happen. We need to be sure that our talking points are on track and we're not getting sideways about anything and going down roads that we don't need to talk about. It's why, um, you know, PMC is very focused on, um, moving forward veteran legislation right now. Melissa Lavasani: Not because we're a veteran organization, but because we're, we see this long-term policy track here. Um, we know where we want to get [00:09:00] to, um. Um, and watching other healthcare issues kind of come up and then go through the VA healthcare system, I think it's a really unique opportunity, um, to utilize the VA as this closed system, the biggest healthcare system in the country to evaluate, uh, how psychedelics operate within systems like that. Melissa Lavasani: And, you know, before they get into, um, other healthcare systems. What do we need to fix? What do we need to pay attention to? What's something that we're paying too much attention to that doesn't necessarily need that much attention? So it's, um, it's a real opportunity to look at psychedelic medicines within a healthcare system and obviously continue to gather the data. Melissa Lavasani: Um, Bergman's Bill emerging, uh, expanding veteran access to emerging treatments. Um, not only mandates the research, it gives the VA authority for this, uh, for running trials and, and creating programs around psychedelic medicines. But also, [00:10:00] one of the great things about it, I think, is it provides an on-ramp for veterans that don't necessarily qualify for clinical trials. Melissa Lavasani: You know, I think that's one of the biggest criticisms of clinical trials is like you're cre you're creating a vacuum for people and people don't live in a vacuum. So we don't necessarily know what psychedelics are gonna look like in real life. Um, but with this expanding veteran access bill that Bergman introduced, it provides the VA an opportunity to provide this access under. Melissa Lavasani: Um, in a, in a safe container with medical supervision while collecting data, um, while ensuring that the veteran that is going through this process has the support systems that it needs. So, um, you know, I think that there's a really unique opportunity here, and like Latrell said, like, we've got one shot at this. Melissa Lavasani: We have people's attention in Congress. Um, now's the time to start acting, and let's be really considerate and thoughtful about what we're doing with it. Joe Moore: Thanks for that, Melissa and Jay, how, [00:11:00] anything to add there on kind of your takeaways from the this, uh, last visit in dc? Jay Kopelman: Yeah, I, I think that Melissa highlighted it really well and there, there were a couple other things that I, I think, you know, you could kind of tie it all together with some other issues that we face in this country, uh, and that. Jay Kopelman: Uh, representative Correa brought up as well, but one of the things I wanted to go back and say is that veterans have kind of led this movement already, right? So, so it's a, it's a good jumping off point, right? That it's something people from both sides of the aisle, from any community in America can get behind. Jay Kopelman: You know, if you think about it, uh, in World War ii, you know, we had a million people serving our population was like, not even 200 million, but now [00:12:00] we have a population of 330 million, and at any given time there might be a million people in uniform, including the Reserve and the National Guard. So it's, it, it's an easy thing to get behind this small part of the population that is willing to sign that contract. Jay Kopelman: Where you are saying, yeah, I'm going to defend my country, possibly at the risk of my l my own life. So that's the first thing. The other thing is that the VA being a closed health system, and they don't have shareholders to answer to, they can take some risks, they can be innovative and be forward thinking in the ways that some other healthcare systems can't. Jay Kopelman: And so they have a perfect opportunity to show that they truly care for their veterans, which don't, I'm not saying they don't, but this would be an [00:13:00] opportunity to show that carrot at a whole different level. Uh, it would allow them to innovate and be a leader in something as, uh, as our friend Jim Hancock will say, you know. Jay Kopelman: When he went to the Naval Academy, they had the world's best shipbuilding program. Why doesn't the VA have the world's best care program for things like TBI and PTSD, which affects, you know, 40 something percent of all veterans, right? So, so there's, there's an opportunity here for the VA to lead from the front. Jay Kopelman: Um, the, these medicines provide, you know, reasonably lasting care where it's kind of a one and done. Whereas with the current systems, the, you know, and, and [00:14:00] again, not to denigrate the VA in any way, they're doing the best job they can with the tools in their toolbox, right? But maybe it's time for a trip to Home Depot. Jay Kopelman: Let's get some new tools. And have some new ways of fixing what's broken, which is really the way of doing things. It's not, veterans aren't broken, we are who we are. Um, but it's a, it's a way to fix what isn't working. So I, I think that, you know, given there's tremendous veteran homelessness still, you know, addiction issues, all these things that do translate to the population at large are things that can be worked on in this one system, the va that can then be shown to have efficacy, have good data, have [00:15:00] good outcomes, and, and take it to the population at large. Joe Moore: Mm-hmm. Brilliant. Thanks for that. And so there was another thing I wanted to pivot to, which is some of the recent press. So we've, um, seen a little bit of press around some, um, in one instance, some bad behavior in Mexico that a FI put out Americans thrive again, put out. And then another case there was a, a recent fatality. Joe Moore: And I think, um, both are tragic. Like we shouldn't be having to deal with this at this point. Um, but there's a lot of things that got us here. Um, it's not necessarily the operator's fault entirely, um, or even at all, honestly, like some medical interventions just carry a lot of risk. Like think, think about like, uh, how risky bypass surgery was in the nineties, right? Joe Moore: Like people were dying a lot from medical interventions and um, you know, this is a major intervention, uh, ibogaine [00:16:00] and also a lot of promise. To help people quite a bit. Um, but as of right now, there's, there's risk. And part of that risk, in my opinion, comes from the inability of organizations to necessarily collaborate. Joe Moore: Like there's no kind of convening body, sitting in the middle, allowing, um, for, and facilitating really good data sharing and learnings. Um, and I don't, I don't necessarily see an organization stepping up and being the, um, the convener for that kind of work. I've heard rumors that something's gonna happen there, and I'm, I'm hopeful I'll always wanna share my opinion on that. Joe Moore: But yeah. I don't know. Jay, from your perspective, is there anything you want to kind of speak to about, uh, these two recent incidents that Americans for Iboga kind of publicized recently? Jay Kopelman: Yeah, so I, I'll echo your sentiment, of course, that these are tragic incidents. Um, and I, [00:17:00] I think that at least in the case of the death at Ambio, AMBIO has done a very good job of talking about it, right? Jay Kopelman: They've been very honest with the information that they have. And like you said, there are risks inherent to these medicines, and it's like anything else in medicine, there are going to be risks. You know, when I went through, uh, when I, when I went through chemo, you know, there were, there are risks. You know, you don't feel well, you get sick. Jay Kopelman: Um, and, and it. There are processes in place to counter that when it happens. And there are processes and, and procedures and safety protocols in place when caring for somebody going through an ibogaine [00:18:00] journey. Uh, when I did it, we had EKG echocardiogram. You're on a heart monitor the entire time they push magnesium via iv. Jay Kopelman: You have to provide a urinalysis sample to make sure that there is nothing in your system that is going to potentially harm you. During the ibogaine, they have, uh, a cardiologist who is monitoring the heart monitors throughout the ibogaine experience. So the, the safety protocols are there. I think it's, I think it's just a matter of. Jay Kopelman: Standardizing them across all, all providers, right? Like, that would be a good thing if people would talk to one another. Um, as, as in any system, right? You've gotta have [00:19:00] some collaboration. You've gotta have standardization, you know, so, you know, they're not called standard operating procedures for nothing. Jay Kopelman: That means that in a, you know, in a given environment, everybody does things the same way. It's true in Navy and Marine Corps, air Force, army Aviation, they have standard operating procedures for every single aircraft. So if you fly, let's say the F 35 now, right? Because it's flown by the Navy, the Marine Corps, and the Air Force. Jay Kopelman: The, the emergency procedures in that airplane are standardized across all three services, so you should have the same, or, you know, with within a couple of different words, the same procedures and processes [00:20:00] across all the providers, right? Like maybe in one document you're gonna change, happy to glad and small dog to puppy, but it's still pretty much the, the same thing. Jay Kopelman: And as a service that provides scholarships to people to go access these medicines and go to these retreats, you know, my criteria is that the, this provider has to be safe. Number one, safety's paramount. It's always gotta be very safe. It should, it has to be effective. And you know, once you have those two things in place, then I have a comfort level saying, okay, yeah, we'll work with this provider. Jay Kopelman: But until those standardized processes are in place, you'll probably see these one-off things. I mean, some providers have been doing this longer than others and have [00:21:00] really figured out, you know, they've, they've cracked the code and, you know, sharing that across the spectrum would be good. Um, but just when these things happen, having a clearing house, right, where everybody can come together and talk about it, you know, like once the facts are known because. Jay Kopelman: To my knowledge, we still don't know all the facts. Like as, you know, as horrible as this is, you still have to talk about like an, has an autopsy been performed? What was found in the patient's system? You know, there, there are things there that we don't know. So we need to, we need to know that before we can start saying, okay, well this is how we can fix that, because we just don't know. Jay Kopelman: And, you know, to their credit, you know, Amio has always been safe to, to the, to the best of my knowledge. You know, I, [00:22:00] I haven't been to Ambio myself, but people that I have worked with have been there. They have observed, they have seen the process. They believe it's safe, and I trust their opinion because they've seen it elsewhere as well. Jay Kopelman: So yeah, having, having that one place where we can all come together when this happens, it, it's almost like it should be mandatory. In the military when there's a training accident, we, you know, we would have to have what's called a safety standout. And you don't do that again for a little while until you figure out, okay, how are we going to mitigate that happening again? Jay Kopelman: Believe me, you can go overboard and we don't want to do that. Like, we don't wanna just stop all care, but maybe stop detox for a week and then come back to it. [00:23:00] Joe Moore: Yeah. A dream would be, let's get like the, I don't know, 10, 20 most popular, uh, or well-known operators together somewhere and just do like a three day debrief. Joe Moore: Hey, everybody, like, here's what we see. Let's work on this together. You know how normal medicine works. And this is, it's hard because this is not necessarily, um, something people feel safe about in America talking about 'cause it's illicit here. Um, I don't understand necessarily how the operations, uh, relate to each other in Mexico, but I think that's something to like the public should dig into. Joe Moore: Like, what, what is this? And I, I'll start digging into that. Um, I, I asked a question recently of somebody like, is there some sort of like back channel signal everybody's using and there's no clear Yes. You know? Um, I think it would be good. That's just a [00:24:00] start, you know, that's like, okay, we can actually kind of say hi and watch out for this to each other. Jay Kopelman: It's not like we don't all know one another, right? Joe Moore: Yes. Jay Kopelman: Like at least three operators we're represented. At the Aspen Ibogaine meeting. So like that could be, and I think there was a panel kind of loosely related to this during Aspen Ibogaine meeting, but Joe Moore: mm-hmm. Jay Kopelman: It, you know, have a breakout where the operators can go sit down and kind of compare notes. Joe Moore: Right. Yeah. Melissa, do you have any, uh, comments on this thread here? And I, I put you on mute if you didn't see that. Um, Melissa Lavasani: all right, I'm off mute. Um, yeah, I think that Jay's hits the nail on the head with the collaboration thing. Um, I think that it's just a [00:25:00] problem across the entire ecosystem, and I think that's just a product of us being relatively new and upcoming field. Melissa Lavasani: Um, uh, it's a product of, you know. Our fundraising community is really small, so organizations feel like they are competing for the same dollars, even though their, their goals are all the same, they have different functions. Um, I think with time, I mean, let's be honest, like if we don't start collaborating and, and the federal government's moving forward, the federal government's gonna coordinate for us. Melissa Lavasani: And not, that might not necessarily be a bad thing, but, you know, we understand this issue to a whole other level that the federal government doesn't, and they're not required to understand it deeply. They just need to know how to really move forward with it the proper way. Um, but I think that it. It's really essential [00:26:00] that we all have this come together moment here so we can avoid things. Melissa Lavasani: Uh, I mean, no one's gonna die from bad advocacy. So like I've, I have a bit of an easier job. Um, but it can a, a absolutely stall efforts, um, to move things forward in Washington DC when, um, one group is saying one thing, another group is saying another thing, like, we're not quite at a point yet where we can have multiple lines of conversation and multiple things moving forward. Melissa Lavasani: Um, you know, for PMC, it's like, just let's get the first thing across the finish line. And we think that is, um, veteran healthcare. And, um, I know there's plenty of other groups out there that, that want the same thing. So, you know, I always, the reason why I put on the Federal Summit last year was I kind of hit my breaking point with a lack of collaboration and I wanted to just bring everyone in the same room and say like, all right, here are the things that we need to talk about. Melissa Lavasani: And I think the goal for this year is, um. To bring people in the same room and say, we talked about [00:27:00] we scratched the surface last year and this is where we need to really put our efforts into. And this is where the opportunities are. Um, I think that is going to, that's going to show the federal government if we can organize ourselves, that they need to take this issue really seriously. Melissa Lavasani: Um, I don't think we've done a great job at that thus far, but I think there's still plenty of time for us to get it together. Um, and I'm hoping with these two, uh, VA bills that are in the house right now and Senate is, is putting together their version of these two bills, um, so that they can move in tandem with each other. Melissa Lavasani: I think that, you know, there's an opportunity here for. Us to show the federal government as an ecosystem, Hey, we, we are so much further ahead and you know, this is what we've organized and here's how we can help you, um, that would make them buy into this issue a bit more and potentially move things forward faster. Melissa Lavasani: Uh, at this point in time, it's, I think that, [00:28:00] you know, psychedelics aren't necessarily the taboo thing that they, they used to be, but there's certainly places that need attention. Um, there's certainly conversations that need to be had, and like I said, like PMC is just one organization that can do this. Um, we can certainly organize and drive forward collaboration, but I, like we alone, cannot cover all this ground and we need the subject matter experts to collaborate with us so we can, you know, once we get in the door, we wanna bring the experts in to talk to these officials about it. Melissa Lavasani: So I. I, I really want listeners to really think about us as a convener of sorts when it comes to federal policy. Um, and you know, I think when, like for example, in the early eighties, a lot of people have made comparisons to the issue of psychedelics to the issue of AIDS research and how you have in a subject matter that's like extremely taboo and a patient population that the government [00:29:00] quite honestly didn't really care about in the early eighties. Melissa Lavasani: But what they did as an ecosystem is really organized themselves, get very clear on what they wanted the federal government to do. And within a matter of a couple years, uh, AIDS research funding was a thing that was happening. And what that, what that did was that ripple effect turned that into basically finding new therapies for something that we thought was a death, death sentence before. Melissa Lavasani: So I think. We just need to look at things in the past that have been really successful, um, and, and try to take the lessons from all of these issues and, and move forward with psychedelics. Joe Moore: Love that. And yes, we always need to be figuring out efficient approaches and where it has been successful in the past is often, um, an opportunity to mimic and, and potentially improve on that. Melissa Lavasani: Yeah. Jay Kopelman: One, one thing I think it's important to add to this part of the conversation is that, [00:30:00] you know, Melissa pointed out there are a number of organizations that are essentially doing the same thing. Jay Kopelman: Um, you know, I like to think we do things a little bit differently at Mission within Foundation in that we don't target any one specific type of service member. We, we work with all veterans. We work with first responders, but. What that leads to is that there are, as far as I've seen, nothing but good intentioned people in this space. Jay Kopelman: You know, people who really care about their patient population, they care about healing, they are trying to do a good job, and more importantly, they're trying to do good. Right? It, it, I think they all see the benefit down the road that this has, [00:31:00] pardon me, not just for veterans, but for society as a whole. Jay Kopelman: And, and ultimately that's where I would like to see this go. You know, I, I would love to see the VA take this. Take up this mantle and, and run with it and provide great data, great outcomes. You know, we are doing some data collection ourselves at Mission within foundation, albeit anecdotal based on surveys given before and after retreats. Jay Kopelman: But we're also working with, uh, Greg Fonzo down at UT Austin on a brain study he's doing that will have 40 patients in it when it's all said and done. And I think we have two more guys to put through that. Uh, and then we'll hit the 40. So there, there's a lot of good here that's being done by some really, really good people who've been doing this for a long time [00:32:00] and want to want nothing more than to, to see this. Jay Kopelman: Come to, come full circle so that we can take care of many, many, many people. Um, you know, like I say, I, I wanna work myself out of a job here. I, I just, I would love to see this happen and then I, you know, I don't have to send guys to Mexico to do this. They can go to their local VA and get the care that they need. Jay Kopelman: Um, but one thing that I don't think we've touched on yet, or regarding that is that the VA isn't designed for that. So it's gonna be a pretty big lift to get the right types of providers into the va with the knowledge, right, with the institutional knowledge of how this should be done, what is safe, what is effective, um, and then it, it's not just providing these medicines to [00:33:00] people and sending them home. Jay Kopelman: You don't just do that, you've gotta have the right therapists on the backend who can provide the integration coaching to the folks who are receiving these medicines. And I'm not just talking, I bga, even with MDMA and psilocybin, you should have a proper period of integration. It helps you to understand how this is going to affect you, what it, what the experience really meant, you know, because it's very difficult sometimes to just interpret it on your own. Jay Kopelman: And so what the experience was and what it meant to you. And, and so it will take some time to spin all that up. But once it's, once it's in place, you know, the sky's the limit. I think. Joe Moore: Kinda curious Jay, about what's, what's going on with Ibogaine at the federal level. Is there anything at VA right now? [00:34:00] Jay Kopelman: At the va? No, not with ibogaine. And, you know, uh, we, we send people specifically for IBOGAINE and five MEO, right? And, and so that, that doesn't preclude my interest in seeing this legislation passed, right? Jay Kopelman: Because it, it will start with something like MDMA or psilocybin, but ultimately it could grow to iboga, right? It the think about the cost savings at, at the va, even with psilocybin, right? Where you could potentially treat somebody with a very inexpensive dose of psilocybin or, or iboga one time, and then you, you don't have to treat them again. Jay Kopelman: Now, if I were, uh, you know, a VA therapist who's not trained in psychedelic trauma therapy. I might be worried [00:35:00] about job security, but it's like with anything, right? Like ultimately it will open pathways for new people to get that training or the existing people to get that training and, and stay on and do that work. Jay Kopelman: Um, which only adds another arrow to their quiver as far as I'm concerned, because this is coming and we're gonna need the people. It's just like ai, right? Like ai, yeah. Some people are gonna lose some jobs initially, and that's unfortunate. But productivity ultimately across all industries will increase and new jobs will be created as a result of that. Jay Kopelman: I mean, I was watching Squawk Box one morning. They were talking about the AI revolution and how there's gonna be a need for 500,000 electricians to. Build these systems that are going to work with the AI [00:36:00] supercomputers and, and so, Joe Moore: mm-hmm. Jay Kopelman: Where, where an opportunity may be lost. I think several more can be gained going forward. Melissa Lavasani: And just to add on what Jay just said there, there's nothing specific going on with Ibogaine at, at the va, but I think this administration is, is taking a real look at addiction in particular. Uh, they just launched, uh, a new initiative, uh, that's really centered on addiction treatments called the Great American Recovery. Melissa Lavasani: And, um, they're dedicating a hundred million dollars towards treating addiction as like a chronic treatable disease and not necessarily a law enforcement issue. So, um, in that initiative there will be federal grant programs for prevention and treatment and recovery. And, um, while this isn't just for psychedelic medicines, uh, I think it's a really great opportunity for the discussion of psychedelics to get elevated to the White House. Melissa Lavasani: Um, [00:37:00] there's also, previous to this announcement last week from the White House, there's been a hundred million dollars that was dedicated at, um, at ARPA h, which is. The advanced research projects, uh, agency for healthcare, um, and that is kind of an agency that's really focused on forward looking, um, treatments and technologies, uh, for, um, a, a whole slew of. Melissa Lavasani: Of issues, but this a hundred million dollars is dedicated to mental health and addiction. So there's a lot of opportunity there as well. So we, while I think, you know, some people are talking about, oh, we need a executive order on Iboga, it's like, well, you know, the, the president is thinking, um, about, you know, what issues can land with his, uh, voting block. Melissa Lavasani: And I think it's, I don't think we necessarily need a specific executive order on Iboga to call this a success. It's like, let's look at what, [00:38:00] um, what's just been announced from the White House. They're, they're all in on. Thinking creatively and finding, uh, new solutions for this. And this is kind of, this aligns with, um, HHS secretaries, uh, Robert F. Melissa Lavasani: Kennedy Junior's goals when he took on this, this role of Health Secretary. Um, addiction has been a discussion that, you know, he has personal, um, a personal tie to from his own experience. And, um, I think when this administration started, there was so much like fervor around the, the dialogue of like, everyone's talking about psychedelics. Melissa Lavasani: It was Secretary Kennedy, it was, uh, secretary Collins at the va. It was FDA Commissioner Marty Macari. And I think that there's like a lot of undue frustration within folks 'cause um, you don't necessarily snap your fingers and change happens in Washington dc This is not the city for that. And it's intentionally designed to move slow so that we can avoid really big mistakes. Melissa Lavasani: Um. [00:39:00] I think we're a year into this administration and these two announcements are, are pretty huge considering, um, you know, the, we, there are known people within domestic policy council that don't, aren't necessarily supportive of psychedelic medicine. So there's a really amazing progress here, and frustrating as it might be to, um, just be waiting for this administration to make some major move. Melissa Lavasani: I think they are making major moves like for Washington, DC These, these are major moves and we just gotta figure out how we can, um, take these initiatives and apply them to the issue of psychedelic medicines. Joe Moore: Thanks, Melissa. Um, yeah, it is, it is interesting like the amount of fervor there was at the beginning. You know, we had, uh. Kind of one of my old lawyers, Matt Zorn, jumped in with the administration. Right. And, um, you know, it was, uh, really cool to [00:40:00] see and hopeful how much energy was going on. It's been a little quiet, kind of feels like a black box a little bit, but I, you know, there was, Melissa Lavasani: that's on me. Melissa Lavasani: Maybe I, we need to be more out in public about like, what's actually happening, because I feel like, like day in and day out, it's just been, you gotta just mm-hmm. Like have that constant beat with the government. Mm-hmm. And, um, it's, it's, it's not the photo ops on the hill, it's the conversations that you have. Melissa Lavasani: It's the dinner parties you go to, it's the fundraisers you attend, you know? Mm-hmm. That's why I, I kind of have to like toot my own horn with PCs. Like, we need to be present here at, at not only on the Hill, not only at the White House, but kind of in the ecosystem of Washington DC itself. There's, it's, there are like power players here. Melissa Lavasani: There are people that are connected that can get things done, like. I mean, the other last week we had a big snow storm. I walked over to my friend's house, um, to have like a little fire sesh with them and our kids, and his next door neighbor came over. He was a member of Congress. I talked about the VA bills, like [00:41:00] we're reaching out to his office now, um, to get them, um, up to speed and hopefully get their co-sponsorship for, uh, the two VA bills. Melissa Lavasani: So, I mean, it, the little conversations you have here are just as important as the big ones with the photo ops. So, um, it, it's, it's really like, you know, building up that momentum and, and finding that time where you can really strike and make something happen. Joe Moore: Mm-hmm. Yeah. Jay, anything to add there? Jay Kopelman: Yeah, I was just gonna say that, you know, I, I, I think the fervor is still there, right? Jay Kopelman: But real life happens. Melissa Lavasani: Yes, Jay Kopelman: yes. And gets in the way, right? So, Melissa Lavasani: yeah, Jay Kopelman: I, I can't imagine how many issues. Secretary Kennedy has every day much less the president. Like there's so many things that they are dealing with on a daily basis, right? It, we, we just have to work to be the squeaky wheel in, in the right way, right. Jay Kopelman: [00:42:00] With the, with the right information at the right time. Like just inundating one of these organizations with noise, it's then it be with Informa, it just becomes noise, right? It it, it doesn't help. So when we have things to say that are meaningful and impactful, we do, and Melissa does an amazing job of that. Jay Kopelman: But, you know, it, it takes time. You know, it's, you know, we're not, this is, this is like turning an aircraft carrier, not a ski boat. Melissa Lavasani: Yeah, Joe Moore: yeah, absolutely. Um, and. It's, it's understandably frustrating, I think for the public and the psychedelic public in particular because we see all this hope, you know, we continue to get frustrated at politics. It's nothing new, right? Um, and we, we wanna see more people get well immediately. [00:43:00] And I, I kind of, Jay from the veteran perspective, I do love the kind of loud voices like, you're making me go to Mexico for this. Joe Moore: I did that and you're making me leave the country for the thing that's gonna fix me. Like, no way. And barely a recognition that this is a valid treatment. You know, like, you know, that is complicated given how medicine is structured here domestically. But it's also, let's face the facts, like the drug war kind of prevented us from being able to do this research in the first place. Joe Moore: You know? Thanks Nixon. And like, how do we actually kind of correct course and say like, we need to spend appropriately on science here so we can heal our own people, including veterans and everybody really. It's a, it's a dire situation out there. Jay Kopelman: Yeah. It, it really is. Um, you know, we were talking briefly about addicts, right? Jay Kopelman: And you know, it's not sexy. People think of addicts as people who are weak-minded, [00:44:00] right? They don't have any self-control. Um, but, but look at, look at the opioid crisis, right? That Brian Hubbard was fighting against in Kentucky for all those years. That that was something that was given to the patient by a doctor that they then became dependent on, and a lot of people died from that. Jay Kopelman: And, and so you, you know, it's, I I don't think it's fair to just put all addicts in a box. Just like it's not fair to put all veterans in a box. Just like it's not fair for doctors, put all their patients in a box. We're individuals. We, we have individual needs. Our, our health is very individual. Like, I, I don't think I should be put in the same box as every other 66-year-old that my doctor sees. Jay Kopelman: It's not fair. [00:45:00] You know, if you, if you took my high school classmates and put us all in a photo, we're all gonna have different needs, right? Like, some look like they're 76, not 66. Some look like they're 56. Not like they're, we, we do things differently. We live our lives differently. And the same is true of addicts. Jay Kopelman: They come to addiction from different places. Not everybody decides they want to just try heroin at a party, and all of a sudden they're addicted. It happens in, in different ways, you know, and the whole fentanyl thing has been so daggum nefarious, right? You know, pushing fentanyl into marijuana. Jay Kopelman: Somebody's smoking a joint and all of a sudden they're addicted to fentanyl or they die. Melissa Lavasani: I think we're having a, Jay Kopelman: it's, it's just not fair to, to say everybody in this pot is the same, or everybody in this one is the same. We have [00:46:00] to look at it differently. Joe Moore: Yeah. I like to zoom one level out and kind of talk about, um, just how hurt we are as a country, as a world really, but as a country specifically, and how many people are out of work for so many. Joe Moore: Difficult reasons and away from their families for so many kind of tragic reasons. And if we can get people back to their families and back to work, a lot of these things start to self-correct, but we have to like have those interventions where we can heal folks and, and get them back. Um, yeah. And you know, everything from trauma, uh, in childhood, you know, adulthood, combat, whatever it is. Joe Moore: Like these things can put people on the sidelines. And Jay, to your point, like you get knee surgery and all of a sudden you're, you know, two years later you're on the hunt for Fentanyl daily. You know, that's tough. It's really tough. Carl Hart does a good job talking about this kind of addiction pipeline and [00:47:00] a few others do as well. Joe Moore: But it's just, you know, kind of putting it in a moral failure bucket. It's not great. I was chatting with somebody about, um, veterans, it's like you come back and you're like, what's gonna make me feel okay right now? And it's not always alcohol. Um, like this is the first thing that made me feel okay, because there's not great treatments and there's, there's a lot of improvements in this kind of like bringing people back from the field that needs to happen. Joe Moore: In my opinion. I, it seems to be shared by a lot of people, but yeah, there's, it's, it's, IGA is gonna be great. It's gonna be really important. I really can't wait for it to be at scale appropriately, but there's a lot of other things we need to fix too, um, so that we can just, you know, not have so many people we need to, you know, spend so much money healing. Joe Moore: Mm-hmm. Jay Kopelman: Yeah. You ahead with that. We don't need the president to sign an executive order to automatically legalize Ibogaine. Right. But it would be nice if he would reschedule it so that [00:48:00] then then researchers could do this research on a larger scale. You know, we could, we could now get some real data that would show the efficacy. Jay Kopelman: And it could be done in a safe environment, you know? And, and so that would be, do Joe Moore: you have any kind of figures, like, like, I've been talking about this for a while, Jay. Like, does it drop the cost a lot of doing research when we deschedule things? Jay Kopelman: I, I would imagine so, because it'll drop the cost of accessing the medicines that are being researched. Jay Kopelman: Right? You, you would have buy-in from more organizations. You know, you might even have a pharma company that comes into this, you know, look at j and j with the ketamine, right? They have, they have a nasal spray version of ketamine that's doing very well. I mean, it's probably their, their biggest revenue [00:49:00] provider for them right now. Jay Kopelman: And, and so. You know, you, it would certainly help and I think, I think it would lower costs of research to have something rescheduled rather than being schedule one. You know it, people are afraid to take chances when you're talking about Schedule one Melissa Lavasani: labs or they just don't have the money to research things that are on Schedule one. Melissa Lavasani: 'cause there's so much in an incredible amount of red tape that you have to go through and, and your facility has to be a certain way and how you contain those, uh, medicines. Oh, researching has to be in a specific container and it's just very cumbersome to research schedule one drugs. So absolutely the cost would go down. Melissa Lavasani: Um, but Joe Moore: yeah, absolutely. Less safes. Melissa Lavasani: Yeah. Joe Moore: Yes. Less uh, Melissa Lavasani: right. Joe Moore: Locked. Yeah. Um, it'll be really interesting when that happens. I'm gonna hold out faith. That we can see some [00:50:00] movement here. Um, because yeah, like why make healing more expensive than it needs to be? I think like that's potentially a protectionist move. Joe Moore: Like, I'm not, I'm not here yet, but, um, look at AbbVie's, uh, acquisition of the Gilgamesh ip. Mm-hmm. Like that's a really interesting move. I think it was $1.2 billion. Mm-hmm. So they're gonna wanna protect that investment. Um, and it's likely going to be an approved medication. Like, I don't, I don't see a world in which it's not an approved medication. Joe Moore: Um, you know, I don't know a timeline, I would say Jay Kopelman: yeah. Joe Moore: Less than six years, just given how much cash they've got. But who knows, like, I haven't followed it too closely. So, and that's an I bga derivative to be clear, everybody, um mm-hmm. If you're not, um, in, in the loop on that, which is hopeful, you know? Joe Moore: Mm-hmm. But I don't know what the efficacy is gonna be with that compared to Ibogaine and then we have to talk about the kind of proprietary molecule stuff. Um, there's like a whole bunch of things that are gonna go on here, and this is one of the reasons why I'm excited about. Federal involvement [00:51:00] because we might actually be able to have some sort of centralized manufacturer, um, or at least the VA could license three or four generic manufacturers per for instance, and that way prices aren't gonna be, you know, eight grand a dose or whatever. Joe Moore: You know, it's, Jay Kopelman: well, I think it's a very exciting time in the space. You know, I, I think that there's the opportunity for innovation. There is the opportunity for collaboration. There's the opportunity for, you know, long-term healing at a very low cost. You know, that we, we have the highest healthcare cost per capita in the world right here in the us. Jay Kopelman: And, and yet we are not the number one health system in the world. So to me, that doesn't add up. So we need to figure out a way to start. Bringing costs down for a lot of people and [00:52:00] at the same time increasing, increasing outcomes. Joe Moore: Absolutely. Yeah. There's a lot of possible outcome improvements here and, and you know, everything from relapse rates, like we hear often about people leaving a clinic and they go and overdose when they get home. Tragically, too common. I think there's everything from, you know, I'm Jay, I'm involved in an organization called the Psychedelics and Pain Association. Joe Moore: We look at chronic pain very seriously, and IGA is something we are really interested in. And if. We could have better, you know, research, there better outcome measures there. Um, you know, perhaps we can have less people on opioids to begin with from chronic pain conditions. Um, Jay Kopelman: yeah, I, I might be due for another Ibogaine journey then, because I deal with chronic pain from Jiujitsu, but, Joe Moore: oh gosh, let's Jay Kopelman: talk Joe Moore: later. Jay Kopelman: That's self inflicted. Some people would say take a month off, but Melissa Lavasani: yeah, Jay Kopelman: I'm [00:53:00] not, I'm not that smart. Joe Moore: Yeah. Um, but you know, this, uh, yeah, this whole thing is gonna be really interesting to see how it plays out. I'm endlessly hopeful pull because I'm still here. Right. I, I've been at this for almost 10 years now, very publicly, and I think we are seeing a lot of movement. Joe Moore: It's not always what we actually wanna see, but it is movement nonetheless. You know, how many people are writing on this now than there were before? Right. You know, we, we have people in New York Times writing somewhat regularly about psychedelics and. Even international media is covering it. What do we have legalization in Australia somewhat recently for psilocybin and MDMA, Czech Republic. Joe Moore: I think Germany made some moves recently. Mm-hmm. Um, really interesting to see how this is gonna just keep shifting. Um Jay Kopelman: mm-hmm. Joe Moore: And I think there's no way that we're not gonna have prescription psychedelics in three years in the United States. It pro probably more like a [00:54:00] year and a half. I don't know. Do you, are you all taking odds? Melissa Lavasani: Yeah. I mean, I think Jay Kopelman: I, I gotta check Cal sheet, see what they're saying. Melissa Lavasani: I think it's safe to say, I mean, this could even come potentially the end of this year, I think, but definitely by the end of 2027, there's gonna be at least one psychedelic that's FDA approved. Joe Moore: Yeah. Yeah. Melissa Lavasani: If you're not counting Ketamine. Joe Moore: Right. Jay Kopelman: I, I mean, I mean it mm-hmm. It, it doesn't make sense that it. Shouldn't be or wouldn't be. Right. The, we've seen the benefits. Mm-hmm. We know what they are. It's at a very low cost, but you have to keep in mind that these things, they need to be done with the right set setting and container. Right. And, and gotta be able to provide that environment. Jay Kopelman: So, but I would, I would love, like I said, I'd love to work myself out of a job here and see this happen, not just for our veterans, [00:55:00] but for everybody. Joe Moore: Mm-hmm. Um, so Melissa, is there a way people can get involved or follow PMC or how can they support your work at PMC? Melissa Lavasani: Yeah, I mean, follow us in social media. Melissa Lavasani: Um, our two biggest platforms are LinkedIn and Instagram. Um, I'm bringing my newsletter back because I'm realizing, um, you know, there is a big gap in, in kind of like the knowledge of Washington DC just in general. What's happening here, and I think, you know, part of PC's value is that we're, we are plugged into conversations that are being had, um, here in the city. Melissa Lavasani: And, you know, we do get a little insight. Um, and I think that that would really quiet a lot of, you know, the, a lot of noise that, um, exists in the, our ecosystem. If, if people just had some clarity on like, what's actually happening or happening here and what are the opportunities and, [00:56:00] um, where do we need more reinforcement? Melissa Lavasani: Um, and, and also, you know, as we're putting together public education campaign, you know. My, like, if I could get everything I wanted like that, that campaign would be this like multi-stakeholder collaborative effort, right? Where we're covering all the ground that we need to cover. We're talking to the patient groups, we're talking to traditional mental health organizations, we're talking to the medical community, we're talking to the general population. Melissa Lavasani: I think that's like another area that we, we just seem to be, um, lacking some effort in. And, you know, ultimately the veteran story's always super compelling. It pulls on your heartstrings. These are our heroes, um, of our country. Like that, that is, that is meaningful. But a lot of the veteran population is small and we need the, like a, the just.[00:57:00] Melissa Lavasani: Basic American living in middle America, um, understanding what psychedelics are so that in, in, in presenting to them the stories that they can relate to, um, because that's how you activate the public and you activate the public and you get them to see what's happening in these clinical trials, what the data's been saying, what the opportunities are with psychedelics, and then they start calling their members of Congress and saying, Hey, there is this. Melissa Lavasani: Bill sitting in Congress and why haven't you signed onto it? And that political pressure, uh, when used the right way can be really powerful. So, um, I think, you know, now we're at this really amazing moment where we have a good amount of congressional offices that are familiar enough with psychedelics that they're willing to move on it. Melissa Lavasani: Um, there's another larger group, uh, that is familiar with psychedelics and will assist and co-sponsor legislation, but there's still so many offices that we haven't been able to get to just 'cause like we don't have all the time in the world and all the manpower in the world to [00:58:00] do it. But, you know, that is one avenue is like the advocates can speak to the, the lawmakers, the experts speak to the lawmakers, and we not, we want the public engaged in this, you know, ultimately, like that's. Melissa Lavasani: Like the best form of harm reduction is having an informed public. So we are not, they're not seeing these media headlines of like, oh, this miracle cure that, um, saved my family. It's like, yes, that can happen psychedelics. I mean, person speaking personally, psychedelics did save my family. But what you miss out of that story is the incredible amount of work I put into myself and put into my mental health to this day to maintain, um, like myself, my, my own agency and like be the parent that I wanna be and be the spouse that I wanna be. Melissa Lavasani: So, um, we, we need to continue to share these stories and we need to continue to collaborate to get this message out because we're all, we're all in the same boat right now. We all want the same things. We want patients to have safe and [00:59:00] affordable access to psychedelic assisted care. Um, and, uh. We're just in the beginning here, so, um, sign up for our newsletter and we can sign up on our website and then follow us on social media. Melissa Lavasani: And, um, I anticipate more and more events, um, happening with PMC and hopefully we can scale up some of these events to be much more public facing, um, as this issue grows. So, um, I'm really excited about the future and I'm, I've been enjoying this partnership with Mission Within. Jay is such a professional and, and it really shows up when he needs to show up and, um, I look forward to more of that in the future. Joe Moore: Fantastic. And Jay, how can people follow along and support mission within Foundation? Jay Kopelman: Yeah, again, social media is gonna be a good way to do that. So we, we are also pretty heavily engaged on LinkedIn and on Instagram. Um, I do [01:00:00] share, uh, a bit of my own stuff as well. On social media. So we have social media pages for Mission within Foundation, and we have a LinkedIn page for mission within foundation. Jay Kopelman: I have my own profiles on both of those as well where people can follow along. Um, one of the other things you know that would probably help get more attention for this is if the general public was more aware of the numbers of professional athletes who are also now pursuing. I began specifically to help treat their traumatic brain injuries and the chronic traumatic encephalopathy that they've, uh, suffered as a result of their time in professional sports or even college sports. Jay Kopelman: And, you know. I people worship these athletes, and I [01:01:00] think that if more of them, like Robert Gall, were more outspoken about these treatments and the healing properties that they've provided them, that it would get even more attention. Um, I think though what Melissa said, you know, I don't wanna parrot anything she just said because she said it perfectly Right. Jay Kopelman: And I'd just be speaking to hear myself talk. Um, but being collaborative the way that we are with PMC and with Melissa is I think, the way to move the needle on this overall. And like she said, if she could get more groups involved in, in these discussions, it would, it would do wonders for us. Joe Moore: Well, thank you both so much for your hard work out there. I always appreciate it when people are showing up and doing this important, [01:02:00] sometimes boring and tedious, but nevertheless sometimes, sometimes exciting work. And um, so yeah, just thank you both and thank you both for showing up here to psychedelics today to join us and I hope we can continue to support you all in the future. Jay Kopelman: Thank you, Joe. Thank you, Joe. It's a pleasure being with you today and with Melissa, of course, always Melissa Lavasani: appreciate the time and space. Joe Moore: Thanks.  

The Deal You Never Knew Existed. Subscribe to our Newsletter: https://theultimatepartner.com/ebook-subscribe/ Check Out UPX: https://theultimatepartner.com/experience/ In this deep dive, Jay McBain reveals the harsh reality of the “28 Moments” in a modern B2B buying journey, using a multi-million dollar SAP deal at AstraZeneca as a wake-up call for vendors. He explains how traditional marketing leads are failing in the “decade of the ecosystem,” where trusted partners like NTT and SoftwareOne are winning deals in “light blue” partnership moments months before a customer ever downloads an ebook. If you aren’t visible in the seven-layer stack or collaborating with the partners who hold the customer’s trust, you aren’t just losing the deal—you're losing the entire market. https://youtu.be/NO-P6X2dTAo?si=8e_sVesqvwaC0M-E Key Takeaways Most vendors lose major deals without ever knowing a transaction was even taking place. The average considered purchase involves 28 distinct moments of research and influence before a sale. Trusted partners often close the deal in the “middle moments” months before the money is actually spent. Traditional marketing leads (MQLs) are often too “flimsy” compared to deep partner-led relationships. Winning in the ecosystem requires being part of a “seven-layer stack” of integrated technology and services. Data-sharing platforms like Crossbeam and Workspan are now essential to seeing the “invisible” pipeline. If you're ready to lead through change, elevate your business, and achieve extraordinary outcomes through the power of partnership—this is your community. At Ultimate Partner® we want leaders like you to join us in the Ultimate Partner Experience – where transformation begins. Key Tags: 28 Moments, Jay McBain, Ecosystem Strategy, AstraZeneca SAP Deal, Seven Layer Stack, B2B Buying Journey, Partner Ecosystem, NTT, SoftwareOne, Channel Strategy, Buyer Intent, Informa TechTarget, Collaborative Selling, Crossbeam, Partner Tap, Workspan, Marketplace Tracking, Co-selling, Tech Integration, Revenue Architecture, Pipeline Growth, Trusted Advisor, Digital Transformation, SAP Optimization, Microsoft AWS Competition. Transcript: [00:00:00] Jay McBain: So if you’re a vendor trying to get into that seven layer stack and you don’t have that relationship, or you don’t have the knowledge that NTT or software one is going in, this will have been a deal that would’ve never hit your pipeline and you’ll have no knowledge. So you will have lost this deal without knowing there was a deal. [00:00:19] Vince Menzione: We’ve been talking 28 moments, but you have a slide. I thought we’d spend some time here because, you know, every conversation with you is about 28 moments, but you finally took the time to analyze one of your deals or one of the deals that was going on with one of your clients and come up with the 28 moments. [00:00:36] Vince Menzione: I thought we’d spend a little time here because this journey slide is a wake up call. Uh, it’s, it’s, it’s all around. Why, why we need to think about all of those. Points we need to think about communities and analysts and marketplaces and proof of concepts and architecture and everything else. I thought maybe you’d take us through this a little bit. [00:00:53] Vince Menzione: ’cause this was for a client, AstraZeneca, by the way. This was, uh, if you don’t know this, ICI Americas was the precursor of mm-hmm. AstraZeneca. It was the first SAP customer in North America. [00:01:03] Jay McBain: Nice. I did [00:01:04] Vince Menzione: not know that. That’s why Microsoft and SAP both headquartered. In that area, near nearby, that client. [00:01:10] Vince Menzione: That’s, uh, news, new news. [00:01:11] Jay McBain: And by the way, this is an SAP deal we’re looking at. Yeah. Uh, so two things here. One is that, um, while I was declaring the decade of the ecosystem, you know, spending time with you and Boca, in between that time we got acquired. Canals, which was Latin for channel, got acquired by oia, part of Informa TechTarget, part of this bigger informa company, which is a Fortune 100 company outta the uk. [00:01:32] Jay McBain: Fantastic. You know, we’re part of this massive organization that is really around buyer intent. How, you know, a tech target and, uh, running hundreds of magazines like Information Week and Computer Week that customers and partners read running hundreds of events, the biggest events on the planet. [00:01:49] Vince Menzione: Crazy [00:01:49] Jay McBain: in B2B, like Black Hat and all these things are run by [00:01:52] Vince Menzione: Yeah, [00:01:53] Jay McBain: informa. [00:01:53] Jay McBain: So it’s got this massive mountain of data. About the 28 moments. So when you start to think if you’re a CMO and you start to think about the early moments, you, you think about somebody reading an ebook or, um, going to a, a webinar or going onto a LinkedIn live just like this one. Yeah, going to a major event and getting a pair of socks from you. [00:02:13] Jay McBain: Um, but anything early in the journey. These are the m qls. These are the things that I need enough of them to be credible before I hand them over to my sales team. ’cause I don’t wanna be laughed out of the room. Hey, they read an ebook. They must, AstraZeneca must be buying millions of dollars of stuff. [00:02:27] Vince Menzione: Traditional marketing lead. [00:02:29] Jay McBain: Traditional marketing lead. So they’re a bit nervous about sharing that. And then later on, the sales motions, the demos and all the progression of the sales. This was the two decades before us, the decade of sales, decade of marketing. But the 28 moments, just to take a step back, if you haven’t heard, it is just a considered purchase. [00:02:46] Jay McBain: It’s about psychology, human psychology. When you go and buy a car, second most expensive thing that you will purchase you on average will go through 28 moments getting ready for that purchase. Some people go through two moments and they just drive to the Cadillac dealership to see Larry, who’s been selling Cadillacs to the family for 80 years. [00:03:04] Jay McBain: Yep. Some people spend 58 moments. That’s probably me. [00:03:07] Vince Menzione: That’s you, a, [00:03:08] Jay McBain: you know, going through all the depreciation, watching every YouTube video, you know, going to the end of the earth. But the average is 28. So you start to think about this, this is the same buying a car considered purchase, that you would buy a million dollars in software. [00:03:21] Jay McBain: From Microsoft or SAP. So when you look at these moments, you start to think, you know, how is you before you buy that car, downloading the invoice price, downloading this month’s backend rebates. Should I buy it in January? Should I buy it in February? All these decisions you make before you get to that dealership, you’re smarter than the salesperson, smarter than the sales manager. [00:03:39] Jay McBain: You know what 5,000 people bought the car for within 50 miles of you? I mean, you’re just so smart. You actually don’t need the dealership anymore. Just Carvana to me, hand me the keys. Exactly. But now in buying technology, hardware, software services, customers are getting this smart. And here’s all the moments they take to get this smart. [00:03:57] Jay McBain: But the thing we always had in mind in this decade of the ecosystem was the 96% there are trusted people. Yeah. Spending decades building that trust that come in in critical moments. They’re not marketing moments, they’re not sales moments. They are fully partnership moments. Yeah. And they’re on this slide in light blue. [00:04:15] Jay McBain: So if you were to look at this deal and, and somebody in marketing is finding these eBooks and webinars and they think there might be something, AWS got a direct hit on their website. So there’s something brewing at AstraZeneca. It, it might be in, it’s a big pharmaceutical company, so you’re probably spending millions of dollars if something’s brewing. [00:04:31] Jay McBain: Yep. But guess what? At the same time, in December on this six month journey. Partners come in with five different paid projects, consulting, advisory design projects, and in this case it was NTT software one, Yash and uh, ISV was there. Yep. But NTT won three different. Deals right at that critical stage. It wasn’t Accenture, it wasn’t Deloitte, NTT at this particular department of AstraZeneca had spent the decades building those relationships. [00:04:58] Jay McBain: So they were the one, and they won critical part of this. And so that’s when the deal is won. And it’s not at April when the money’s being spent. Yeah, it’s, it’s not in March when a couple more ISVs joined the mix, that seven layer stack that solves this particular problem, it was right there. So if you’re a vendor trying to get into that seven layer stack and you don’t have that relationship, or you don’t have the knowledge that NTT or software one is going in, this will have been a deal that would’ve never hit your pipeline and you’ll have no knowledge. [00:05:30] Jay McBain: So you will have lost this deal without knowing there was a deal, which makes up again, the majority of your tam. [00:05:34] Vince Menzione: Yeah. [00:05:35] Jay McBain: But what if I did have this agentic ability to see this deal coming, and I’m a cybersecurity company, I’m just competing for layer five of the deal, but I know that it’s all happening in December. [00:05:46] Jay McBain: So the two things that jump out on this particular slide is one, they don’t just show up in December. [00:05:51] Vince Menzione: Yeah, [00:05:51] Jay McBain: this went closed one in their Salesforce CRM in August, September, well, before the customer ever read an ebook. So now you’re not dealing with a flimsy MQL. You’re dealing with a couple of great, you know, top partner 1000 sized firms. [00:06:09] Jay McBain: One of them is a partner, 30 firm. [00:06:11] Vince Menzione: Exactly. [00:06:12] Jay McBain: That is absolutely going into and earning hundreds of thousands of dollars in services to guide the customer to a millions of dollars in purchase. And, and you can imagine in that boardroom. With A CMO saying, Hey, I got this stuff here. And the head of channels or partnerships saying, no, no, this is real. [00:06:32] Jay McBain: Here’s the names, faces, and places. Yeah. And here’s how it’s happening. And this is exactly, this is the Gantt chart, this is the show up, this is the project, this is the outcome. This is exactly how it’s playing out. Now if I could go back and the board and the C-suite should be asking us, well, how many more deals like this can you see? [00:06:50] Vince Menzione: Yeah. [00:06:51] Jay McBain: If our TAM is, you know, how many billions of dollars? Could you double our pipeline by seeing more of these middle moments? And if we got a couple of months to spend with these partners before they get in front of the customer, could they build more of our portfolio into the deal so we’re not just layer five, maybe we’re layer three and layer five. [00:07:10] Vince Menzione: This slide screams at me. Integr Tech integration Cha. A partner channel integration of tech, uh, whether it’s Crossbeam, whether it’s Partner Tap, whether it’s work span, or any of these other technologies, tackle any of these technologies that are tracking marketplace, that are tracking partner to partner, co-selling. [00:07:30] Vince Menzione: Getting the integration points. The only way to really understand the situation here, because this is a multinational company. Yeah. It’s being touched at all PO points around the globe. And to understand who’s calling who, who’s influencing who, and getting a real view, you know, a uber view of what that looks like is super important. [00:07:47] Jay McBain: It is. And you know, if I’m trying to sell like a cross beam or partner tab or work span or something into my executive team, I’m just showing them this slide. [00:07:54] Vince Menzione: Exactly. [00:07:54] Jay McBain: Would you like to know about this deal? Like you see, October is the start of the timeline here. Would you like to know about this deal in August, September? [00:08:00] Vince Menzione: Yep. [00:08:01] Jay McBain: Would you like to know about it automatically? Again, we’re not waiting for somebody, a human in a cubicle to go fill out a form. We’re not waiting for them to call somebody at our in, in a cubicle at our company. Yeah. We’re literally age genically sharing platforms, and so when this triggers that AstraZeneca and now triggers in our CRM system as well, our team on AstraZeneca gets notified and it gets notified in September before the 28 moments even starts. [00:08:27] Jay McBain: This, the power of this, of doubling, tripling your pipeline and then winning a bigger yield, a bigger percentage of that pipeline. This is the holy grail of our industry, and no one’s gonna get to a hundred percent. You’re not gonna have a hundred percent of your tam covered by your pipeline. No one’s gonna win a hundred percent of that. [00:08:43] Jay McBain: But again, we only have to be 10 or 20% better than our competitors and we need to start moving on this now. [00:08:50] Vince Menzione: So your imperative for the partners here, well everyone watching here today, I mean, this screams to me build your ecosystem strategy in such a strong and succinct way. What else would you say to them? [00:09:00] Jay McBain: I mean, the second thing that jumps out, you see two AWS direct touches here. This is something that this would be inbound. This AWS would see this deal in their pipeline. [00:09:09] Vince Menzione: Yeah. [00:09:10] Jay McBain: Because the customer came to them. AWS lost this deal. Crazy. So Microsoft won this deal. I, I mentioned Microsoft outgrowing AWS Yeah. [00:09:19] Jay McBain: ’cause in this particular case, NTT and Software One and Yash came in with Microsoft. Yeah. To solve an SAP optimization, Microsoft, and, you know, seven layer deal. So whether you’re in AWS, whether you’re in Microsoft, whether you’re anywhere else in this industry, you’re thinking like, you’re not gonna probably overtake what happens in December. [00:09:39] Jay McBain: These are the most trusted, smartest people in the room. And whatever happens in those projects is the seven layer stack the customer’s gonna buy in March, April. So I, I start to think about this and go, I need to win. ’cause NTT has a wonderful relationship with AWS. [00:09:55] Vince Menzione: They do, [00:09:56] Jay McBain: I mean, partner of the year level. [00:09:57] Jay McBain: I mean, they’ve got 10,000 people certified. I mean, there’s just a, you know, there’s no one at AWS that, um, you know, would take a, a loss here because it’s a wonderful relationship. And Software One, they [00:10:09] Vince Menzione: go back to Microsoft actually 30, 40 years though they do. They were Dimension data before that. Yeah. [00:10:14] Vince Menzione: And they have the long hit Legacy And Software One. Software one as well. You, [00:10:19] Jay McBain: you know, well Software one is Microsoft’s biggest reseller, uh, in Europe. And now with Crayon, you know, one of the biggest in the world. So I would be nervous if I was looking at this and saw Software one coming in with NTT and watching these things take place if I were able to see this back in September, October and work with these companies. [00:10:38] Jay McBain: That’s where kind of Microsoft came into the picture. And this never hit Microsoft’s pipeline. No Microsoft salesperson ever worked on it, but millions of dollars came to Microsoft. Yeah. Uh, out of this deal. So there are examples of where Microsoft gets touched and AWS wins the deal. So this isn’t meant to say that it happens in every case, but it’s meant to say data rules the future, and agent ai, the ability to plumb in these boxes. [00:11:00] Jay McBain: Working with Informa tech, target people that can plumb in the boxes for you with third party data, helping you with the light blue boxes. We gotta be obsessed over these light blue boxes. [00:11:11] Vince Menzione: It’s incredible. The Ultimate Partner Winter Retreat is gonna be here in the Boca Studio. This is the third year that we’re gonna be here in Boca. [00:11:21] Vince Menzione: This is always a favorite of our community members, our executive members, our sponsors and speakers. We’ll all be here in the studio, which is a really intimate setting. We can see upwards of 40, 50 people. Uh, we’ll be hosting an incredible dinner at the Boca Resort overlooking the golf course. That’s an incredible property and, uh, we’d love to have you join us. [00:11:45] Vince Menzione: Thank you for being part of the ultimate Partner community, and I hope to see you this year at one of our events. Thank you.